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ABSTRACT 
Inter-individual differences in strength are not fully explained by muscle size, suggesting 
that muscle specific tension [force per unit physiological cross-sectional area (PCSA)] 
varies between untrained individuals. Furthermore, many reports demonstrate greater gains 
in muscle strength than size following resistance training, thus indicating an increase in 
specific tension. Moreover, there is considerable variation in the response to training that 
may have a genetic origin. The aims of the work described in this thesis were i) to examine 
the degree of variability in muscle specific tension; ii) to investigate whether specific 
tension changed following resistance training; iii) to quantify the variability in the response 
of human muscle to resistance training; iv) to identify gene variants that may be associated 
with the variable training responses. In a group of untrained young men and before and 
after 9 weeks of resistance training, the quadriceps femoris (QF) muscle specific tension 
was calculated from the maximum isometric voluntary contraction (MVC) torque, taking 
into account the contribution of voluntary activation, antagonist muscle co-activation, 
moment arm length, QF volume, muscle fascicle length and pennation angle. Correcting 
for these factors made little difference to the between subjects variance of MVC torque, 
thus demonstrating that muscle specific tension varies considerably between individuals. 
Resistance training increased QF muscle force much more than PCSA, indicating that most 
of the increase in force was a result of increased specific tension. This increase was not 
associated with a change in myosin heavy chain expression and was not accompanied by 
an increase in single fibre specific tension, or an increase in power per unit muscle volume 
measured during isokinetic cycling. The results are consistent with an increase in lateral 
force transmission in the muscle. Substantial variation in the training responses was 
observed and the final part of this thesis is concerned with linking this variation with 
specific gene variants. 
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ACSA  Anatomical cross-sectional area 
fCSA  Muscle fibre cross-sectional area 
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Of all the tissues in the human body, skeletal muscle is probably one of the most 
conveniently studied since its outputs, force and movement, are relatively easy to measure. 
Consequently, there is an extensive body of work documenting the differences in strength 
between healthy individuals of the same age (Maughan et al., 1983; Kanehisa et al., 1994; 
Hubal et al., 2005; Williams et al., 2005), between people of different ages (Hakkinen et 
al., 1998; Akima et al., 2001; Morse et al., 2008), between men and women (Kanehisa et 
al., 1994; Akima et al., 2001; Hubal et al., 2005), between athletes of different types 
(Hakkinen et al., 1984; Tesch & Karlsson, 1985; Blazevich et al., 2003) and of the effects 
of both resistance (Rutherford & Jones, 1986; Jones & Rutherford, 1987; Narici et al., 
1989; Narici et al., 1996b; Reeves et al., 2004a) and endurance (Campos et al., 2002; 
McCarthy et al., 2002; Putman et al., 2004) training. At the subcellular level, the regular 
arrangement of the contractile proteins, actin and myosin, has made it possible to 
understand in great detail how the interaction of these two molecules results in the 
characteristic outputs of force and movement. There are, however, lacunae in our 
knowledge when it comes to bridging the gap between what is known at the molecular and 
subcellular level and what is observed at the level of the whole human muscle. The work 
described in this thesis is concerned with three such areas; 1) the relationship between 
muscle size and the force and power that it can generate; 2) the effects of strength training 
on these relationships; 3) the variation between individuals in their response to resistance 
training.  
 
The considerable variation in muscle strength between healthy, untrained individuals of 
similar age (Maughan et al., 1983; Chapman et al., 1984; Kanehisa et al., 1994; Bamman 
et al., 2000; Akima et al., 2001; Fukunaga et al., 2001) appears to be only partly explained 
by differences in muscle size, which implies that the maximum force per unit cross-
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sectional area (CSA) of muscle varies between people. There are numerous neural and 
peripheral factors that might explain this inter-individual variability in force per unit CSA, 
such as differences in the level of voluntary activation, antagonist muscle co-activation, 
moment arm length, muscle fibre length and pennation angle, and fibre-type composition. 
Despite considerable interest in these matters over the last 50 years, the contribution of 
each of these factors to the variation in strength in the untrained state is still not known. 
Furthermore, if the force of a maximally activated muscle were proportional to its CSA, as 
is conventionally thought (see below), then resistance training would be expected to 
increase muscle strength and size proportionately. Yet, the literature abounds in studies 
that report larger gains in strength than muscle CSA following progressive resistance 
training (Ikai & Fukunaga, 1970; Moritani & deVries, 1979; Young et al., 1983; Jones & 
Rutherford, 1987; Davies et al., 1988; Narici et al., 1989; Narici et al., 1996b; Ferri et al., 
2003). As with the variation in force per unit CSA mentioned above, there could be several 
explanations for this phenomenon but the precise role that each factor plays in increasing 
muscle strength has yet to be established. Furthermore, there appears to be considerable 
variation in the way human muscle responds to resistance training, with some people 
experiencing much greater gains in strength and muscle size than others (Hubal et al., 
2005) but the causes for this variance are as yet unknown. This variability in training 
response has received little attention in the scientific literature possibly because these 
observations have been considered artefacts of measurement error or due to variations of 
effort invested by the participants in the training programme. More recently, however, 
there has been great interest in this variable training response in relation to differences in 
genotype (Thomis et al., 2004; Clarkson et al., 2005a; Pescatello et al., 2006; Charbonneau 
et al., 2008). One major deficiency of these studies, however, is that relatively simple 
measures of training outcome were often employed, such as the maximum load that can be 
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lifted during one repetition (1 RM) or maximum voluntary contraction (MVC) and 
anatomical cross-sectional area (ACSA), rather than the true maximum muscle force and 
physiological CSA (PCSA). Information obtained from a smaller, more controlled study 
might help determine the main factors that contribute to the variable increase in strength 
following resistance exercise. Such factors include changes in muscle volume, muscle 
architecture, muscle fibre-type composition, as well as neural adaptations. The extent to 
which these factors respond to training is likely to be determined by different genes, and 
elucidation of the most important factor(s) may help future investigations discover gene 
variants that are associated with the response to resistance training.  
 
An overview of skeletal muscle structure and function 
The main function of skeletal muscle is to enable movement by generating force and acting 
on the bone to which the muscle is attached. Skeletal muscle comprises numerous bundles 
of long, thin cells, or muscle fibres, each containing a multitude of myofibrils. Each 
myofibril is composed of myofilaments (comprising the contractile proteins, actin and 
myosin) and a variety of structural proteins, all arranged in a regular configuration 
throughout the length of the myofibril, so as to form a series of contractile components, or 
sarcomeres (Fig. 1.1). The length of the myofibril and thus the muscle fibre is determined 
by the number of sarcomeres arranged in series, while the fibre cross-sectional area (fCSA) 
is primarily determined by the number of sarcomeres arranged in parallel (Fig. 1.2).  
 
Chapter 1 General introduction 
 
 
5
 
Fig. 1.1 Adapted from Jones et al. (2004). An overview of skeletal muscle structure, from the whole muscle 
to the individual myofibril (A) and from the myofibril to the contractile proteins that constitute the sarcomere 
(B), illustrating the striated appearance of skeletal muscle via an electron micrograph of two sarcomeres and 
the longitudinal and cross-sectional arrangement of the thick (myosin) and thin (actin) filaments  
 
According to the sliding filament theory (Huxley, 1957), the interaction between the thick 
(myosin) and thin (actin) filaments causes the sarcomere and therefore the muscle fibre to 
contract and produce force. The maximal amount of force that can be generated is 
dependant upon the number of sarcomeres arranged in parallel (Fig. 1.2), while the number 
of serial sarcomeres, and therefore the fibre length, is one of the determinants of the 
maximal speed at which the fibre can contract. Thus, as power output is the product of 
force x velocity, both muscles in the example given in Fig. 1.2 should give the same power 
output, as both have the same volume (muscle length x CSA). Therefore, muscle CSA is 
Chapter 1 General introduction 
 
 
6
expected to be the predominant factor that determines the variability in maximum 
voluntary force produced between people, while muscle volume is likely to be the main 
determinant in explaining inter-individual differences in power output. However, the 
determinants of in vivo muscle structure and function are a lot more complex, as the 
relationship between muscle CSA and force output only applies to a maximally activated 
muscle. Furthermore, muscle fibres do not all have the same contractile properties and the 
addition of non-contractile material is likely to affect the ability to generate force and 
power at the whole muscle level.  
 
 
Fig. 1.2 (Jones, 1992). Force generated by sarcomeres in (A) series and in (B) parallel. In A, four sarcomeres 
are arranged in series. When activated, the forces F1 and F2 are opposed, leaving only F3 to exert force at the 
ends of the muscle. In B, the same number of actin and myosin filaments are arranged in parallel to give four 
times the isometric force of A  
 
Voluntary muscle activation 
To contract and generate force, each muscle fibre is innervated by one of the many axonal 
branches of a motoneuron. All the individual muscle fibres that are innervated by the same 
motoneuron form a motor unit, which will differ in size and type, according to the total 
number of fibres innervated and the contractile characteristics of those fibres (Fig. 1.3). 
Once an action potential has passed down the axonal branches to the neuro-muscular 
junction, the release of acetylcholine from the synapse causes depolarisation of the 
sarcolemma (the muscle fibre plasma membrane), via interaction of acetylcholine with its 
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receptors on the post-synaptic membrane. The action potential is propagated along the 
surface membrane and into the transverse-tubuli, which leads to the release of calcium ions 
(Ca2+) from the sarcoplasmic reticulum. The Ca2+ binds to troponin C on the actin filament, 
causing a conformational change of the tropomyosin that exposes the myosin binding sites. 
This whole process is called excitation-contraction coupling, as the excitation by neural 
stimulation is coupled to the resulting muscle contraction. The myosin heads attach to the 
actin filament and, with the hydrolysis of adenosine tri-phosphate, the cross bridge power 
stroke occurs, drawing the Z-lines of the sarcomere closer together, thus causing the 
muscle to contract.  
 
Fig. 1.3 (Jones et al., 2004). Concept of the motor unit. A motor unit consists of the motoneuron and all the 
scattered muscle fibres that it innervates  
 
The level of muscle activation depends on the number of motor units recruited (orderly 
recruitment of motor units) and on the firing frequency of the motoneurons that activate 
the muscle fibres in their units (rate coding). The smaller motoneurons innervating slow 
muscle fibres are predominantly recruited at low force levels but as the force intensity 
increases, the larger motoneurons innervating the faster muscle fibres are recruited, which 
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is known as Henneman’s size principle (Henneman et al., 1974). Maximal activation of a 
muscle requires that all motor units are recruited and that they are each stimulated at their 
optimal firing frequency. There is evidence to suggest that untrained individuals are 
incapable of fully activating their muscle voluntarily (Moritani & deVries, 1979; Hakkinen 
et al., 1998), while other investigators have reported 100% activation in their participants 
prior to training (Komi & Buskirk, 1972; Thorstensson et al., 1976; Jones & Rutherford, 
1987; Davies et al., 1988). The reason for this discrepancy is unclear but differences in 
methodologies used to assess voluntary activation might offer an explanation. For 
example, recording electromyography (EMG) from a single point overlying the muscle of 
interest is associated with many technical problems, such as the positioning of the surface 
electrodes relative to the muscle and the impedance of the skin and underlying tissues, all 
of which are critical in determining the size of the EMG signal. The interpolated twitch 
technique (ITT, Fig. 1.4) and variations on this method have been used extensively to 
assess activation (Rutherford et al., 1986b; Jones & Rutherford, 1987; Allen et al., 1995; 
Allen et al., 1998; Harridge et al., 1999; Folland et al., 2000; Scaglioni et al., 2002; 
Reeves et al., 2004a, b; Williams et al., 2005; Bampouras et al., 2006; Folland & 
Williams, 2007). Comparing the force obtained by supramaximal electrical stimulation of a 
muscle at rest with the additional force obtained by superimposing this level of stimulation 
during an MVC, allows the level of voluntary muscle activation to be reliably estimated.  
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Fig. 1.4 Superimposed electrical stimulation used to determine the level of voluntary muscle activation. The 
quadriceps femoris muscle was stimulated with a single twitch (represented by an arrow) before and during 
MVC. This torque trace was taken from one of the participants of the studies described in the current thesis  
 
The consequence of not accounting for voluntary activation capacity could be an 
inaccurate assessment of maximum muscle force, and inter-individual differences in 
activation capacity will likely contribute to the inter-individual variability in muscle 
strength. Furthermore, activation capacity has been shown to increase following resistance 
training (Scaglioni et al., 2002; Reeves et al., 2004a) and might explain a proportion of the 
strength gain following training. A variable increase in the level of voluntary activation 
(Scaglioni et al., 2002) will undoubtedly have implications for a variable response to 
strength training.  
 
Antagonist muscle co-activation 
When a joint moment is created, the generated torque is the result of the action of several 
muscles, namely the agonists, all pulling in the same direction over that joint and a certain 
amount of force produced by antagonist muscles, pulling in the opposite direction. It is 
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thought that antagonist muscle co-activation around the knee occurs in order to stabilise 
the joint and reduce shearing movements (Hortobagyi & Devita, 2006). The level of 
antagonist co-activation varies between healthy, untrained people of similar age (Carolan 
& Cafarelli, 1992; Macaluso et al., 2002; De Vito et al., 2003; Reeves et al., 2004a). 
Therefore, differing levels of antagonist muscle co-activation between untrained 
individuals are likely to explain a certain amount of the inter-individual variability in 
agonist muscle strength. Similarly, decreased antagonist muscle co-activation following 
strength training, as shown by some investigators (Carolan & Cafarelli, 1992; Hakkinen et 
al., 1998; Hakkinen et al., 2000), would have implications for the calculated training-
induced change in muscle force.  
 
Muscle-tendon moment arm  
To obtain a realistic estimate of maximally activated muscle force in vivo, not only is it 
essential that the levels of voluntary muscle activation and antagonist muscle co-activation 
are accounted for but also the muscle-tendon moment arm, which is determined by the 
anatomical constraints of the skeleton (Maganaris et al., 2001). During knee joint 
extension, it is the patellar tendon moment arm (dPT) that acts as the leverage of the 
effective force transmitted to the tibia during contractions of the quadriceps femoris 
muscle (Fig. 1.5). Using sophisticated methods, such as magnetic resonance imaging 
(MRI) and X-ray video, the dPT has been accurately quantified in vivo in humans 
(Baltzopoulos, 1995; Tsaopoulos et al., 2006). However, the dPT has been shown to differ 
greatly from person to person (Tsaopoulos et al., 2007b), which would have implications 
for inter-individual variability in joint moment. Moreover, dPT is known to change 
according to the knee joint angle (Baltzopoulos, 1995) and as MVC torque changes as a 
function of joint angle (Sale et al., 1982; Reeves et al., 2004b), accurate measurements of 
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maximum muscle force are dependent upon estimations of dPT at the joint angle at which 
peak MVC occurs (the optimum angle). Furthermore, the optimum angle has been shown 
to change as a consequence of resistance training (Reeves et al., 2004b), which would have 
implications for the calculated change in maximum muscle force.  
 
 
Fig. 1.5 A sagittal MRI scan of the knee joint, from which the patellar tendon (PT) moment arm (dPT) can be 
measured. dPT is defined as the perpendicular distance from the tibiofemoral “contact point” (TFCP) to the 
PT. This scan was taken from one of the participants in the studies described in the current thesis  
 
Length-tension relationship and physiological cross-sectional area  
Although maximally activated skeletal muscle force is governed by the number of parallel-
aligned sarcomeres, force is determined by the degree of overlap between the actin and 
myosin filaments within the sarcomere (Gordon et al., 1966), as shown in Fig. 1.6. If the 
sarcomere length is too short or too long, i.e. the interaction of the actin and myosin 
filaments either exceeds or does not reach optimum overlap for producing maximum 
tension (~2.5 µm in human muscle fibres), force output decreases (Fig. 1.6). Therefore, to 
measure the true maximum isometric force of a muscle, it is essential that the muscle is at 
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12 
its optimum length for producing maximum force. Thus, it follows that when measuring 
the muscle force over a joint, the joint should be set at the angle at which the muscle fibres 
of the muscle or group of muscles are at optimum length for producing maximum force 
(Maganaris et al., 2001; Reeves et al., 2004a, b).  
 
 
Fig. 1.6 Adapted from Jones et al. (2004). A, Isometric force generated at different sarcomere lengths (I-IV). 
B, arrangement of filaments at the different lengths. At lengths less than 2.0 µm thin filaments begin to 
overlap and at still shorter lengths the thick filaments come into contact with the Z lines. Values are for frog 
muscle (Gordon et al., 1966); mammalian thin filaments are slightly longer, so the corresponding sarcomere 
lengths are: I, 4.0 µm; II, 2.5 µm; III, 2.4 µm; IV, 1.6 µm  
 
Furthermore, the possibility exists that fibre length is increased as a consequence of a 
training-induced addition of serial sarcomeres (Reeves et al., 2004b, a). Such a change in 
length would shift the fibre length-tension relationship to the right (Fig. 1.7), which would 
affect the joint angle at which peak MVC is measured (Reeves et al., 2004b). An 
additional factor that must be recognized when measuring muscle force in vivo is tendon 
compliance and how that affects the muscle length-tension relationship. In short, a more 
compliant tendon would allow greater shortening of the muscle fibres at a set joint angle, 
thus altering the joint angle-MVC relationship to a less extended joint angle. Resistance 
training, however, is known to increase tendon stiffness (Reeves et al., 2003b; Kongsgaard 
et al., 2007; Seynnes et al., 2009), thus reducing the optimum joint angle following 
training (Reeves et al., 2004b). This further highlights the importance of measuring muscle 
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strength at the joint angle at which peak MVC is obtained.  
 
 
Fig. 1.7 Adapted from Jones et al. (1989). The possible effect of resistance training on muscle fibre length 
and the consequences for the length-tension relationship. Training may lead to an increase in the numbers of 
serial sarcomeres in each muscle fibre and a subsequent shift in the length-tension relationship to the right. a, 
before training; b, after training.  
 
Muscle architecture 
Due to the technical difficulties of measuring the cross-sectional area of the total number 
of muscle fibres [represented by the PCSA (Powell et al., 1984)] of complex human 
muscles in vivo, the anatomical CSA (ACSA, the area of muscle perpendicular to the 
longitudinal axis of the limb) has often been used as an index of muscle size (Maughan et 
al., 1983; Chapman et al., 1984; Kanehisa et al., 1994; Akima et al., 2001; Hubal et al., 
2005). However, ACSA only explains ~50% of the variability in MVC between untrained 
individuals (Maughan et al., 1983; Chapman et al., 1984; Bamman et al., 2000), which 
could be due to both neural and architectural factors. The majority of skeletal muscles have 
a complex architecture, that is to say the muscle fibre lengths and angle at which the fibres 
insert into the aponeurosis, known as the pennation angle, differ between muscles 
(Alexander & Vernon, 1975) and for the same muscle between individuals (Kawakami et 
al., 2006). Using ultrasonography it is now possible to assess the architecture of human 
muscles in vivo (Henriksson-Larsen et al., 1992; Rutherford & Jones, 1992; Kawakami et 
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al., 1993). Each bundle of muscle fibres, known as a muscle fascicle, is encased by a 
sheath of connective tissue called the perimysium (Fig. 1.1). Thus, the fascicular paths can 
be identified from sonographs as the interspaces between the echoes arising from the 
surrounding perimysial tissue and the fascicle pennation angle is defined as the angle 
between the fascicular path and the aponeurosis of the muscle (Fig. 1.8).  
 
 
Fig. 1.8 A sagittal ultrasound image of the vastus lateralis (VL) muscle, highlighting the fascicular path, the 
fascicle pennation angle (θp) and the upper and lower aponeuroses. This scan was taken from one of the 
participants in the studies of the current thesis  
 
The pennate arrangement of muscle fibres allows a greater amount of contractile material 
to attach to a limited area of tendon (Alexander & Vernon, 1975; Gollnick et al., 1981; 
Aagaard et al., 2001), thus increasing the force generating capacity of the muscle. 
However, a trade-off exists between the increase in force generating capacity and the 
concomitant reduction in force resolved at the tendon as a function of the cosine of the 
pennation angle, where net tendon force will continue to increase up to a pennation angle 
of 45° (Alexander & Vernon, 1975). The larger the fascicle pennation angle, the less 
representative the ACSA is of the PCSA (Alexander & Vernon, 1975), a point illustrated 
in Fig. 1.9. Using a combination of MRI and ultrasonography, PCSA can be estimated in 
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vivo from the ratio of muscle volume to fascicle length (Maganaris et al., 2001; Reeves et 
al., 2004a). Further, to obtain an accurate assessment of the muscle strength-size 
relationship, it is vital that the PCSA is estimated when the muscle fibres are at their 
optimum length for generating maximum force (Chow et al., 1999; Maganaris et al., 2001; 
Reeves et al., 2004a).  
 
 
Fig. 1.9 Effect of pennation angle on the size of muscle fibre that can attach to the tendon. θa and θb are 
angles of pennation; fCSA and ACSA are the fibre and anatomical cross-sectional areas, respectively; 
“Footprint” is the area of tendon occupied by each muscle fibre. Increasing the pennation angle from θa to θb 
allows more contractile material to attach to the tendon (causing an increase from fCSAa to fCSAb) without 
increasing the footprint, thus and enabling the fibre to produce more force. However, as the fibre length has 
decreased from (i) to (ii), so the ACSA remains the same, thus demonstrating how differences in muscle 
architecture between people can affect muscle force output and how ACSA can underestimate PCSA  
 
A number of studies have demonstrated that strength training induces an increase in 
muscle fascicle pennation angle (Kawakami et al., 1995; Aagaard et al., 2001; Reeves et 
al., 2004a), which has been attributed to muscle fibre hypertrophy (Staron et al., 1990; 
Staron et al., 1994; Aagaard et al., 2001; Campos et al., 2002). However, not only does 
muscle fascicle pennation angle vary between untrained individuals (Kawakami et al., 
2006) but also in the extent to which it changes with training (Reeves et al., 2004b). This 
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emphasizes the importance of measuring muscle architecture, in order to obtain an accurate 
account of the inter-individual variability in strength and the true changes in muscle force.  
 
Muscle fibre type 
As described above, skeletal muscle is composed of different types of motor units, 
depending on the contractile properties of the innervated muscle fibres. Human muscle 
fibres can be broadly classified into three types (I, IIa and IIx) using their histochemical 
staining patterns when staining for myosin adenosine triphosphatase (mATPase) after pre-
incubations at different pH (Brooke & Kaiser, 1970). Although this staining procedure 
shows the distribution of particular fibres within a cross-section, it appears problematic in 
distinguishing hybrid fibres, such as type IIa/IIx. An alternative method is to determine the 
myosin heavy chain (MyHC) isoform composition of a muscle (Fig. 1.10). The advantage 
is that the proportions of the different MyHC isoforms within a muscle can be readily 
obtained, although information on how these isoforms or fibres are distributed within the 
muscle is not accessible.  
 
 
Fig. 1.10 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) protein separations 
showing MyHC I, MyHC IIA, and MyHC IIX bands from the vastus lateralis muscle of one participant 
before (Pre) and after (Post) nine weeks of resistance training. This example was taken from the study 
described in Chapter 4 of the current thesis 
 
For fibres of the same length, it is the mATPase in the globular (S-1 unit) region of the 
myosin molecule of the different MyHC isoforms that is the basis for the differences in 
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speed of shortening of fibres. In fact, there is a close correlation between the maximal 
shortening velocity of a muscle and its mATPase activity (Barany, 1967), Fig. 1.11.  
 
 
Fig. 1.11 (Jones et al., 2004). Relationship between maximal shortening velocity and actin-activated myosin 
ATP-ase activity from various animal species [redrawn from the data of Barany (1967)] 
 
The different fibre types each have their own myosin isoform (Staron & Pette, 1986; 
Staron, 1991; Adams et al., 1993b; Fry et al., 1994) and the greater mATPase activity of 
muscle fibres containing purely MyHC IIX allows them to contract faster than fibres 
comprising only MyHC IIA, which in turn have faster contractile properties than pure 
MyHC type I fibres (Bottinelli et al., 1996; Li & Larsson, 1996; Bottinelli & Reggiani, 
2000; D'Antona et al., 2006; Degens & Larsson, 2007). Consequently, type II fibres are 
able to produce more force at any given shortening velocity than type I fibres. Therefore, 
there is an upward shift in force-velocity relationship from type I to type II fibres, which 
leads to type II fibres generating a higher power output than slower type I fibres, as 
illustrated in Fig. 1.12. In addition to speed, there are studies that suggest that type IIX and 
type IIA fibres are intrinsically stronger than type I fibres (Bottinelli et al., 1996; D'Antona 
et al., 2006; Pansarasa et al., 2009), although this is not a universal conclusion (Larsson & 
Moss, 1993; Ottenheijm et al., 2005; Gilliver et al., 2009). Moreover, resistance training 
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may increase the specific tension of isolated single fibres in human muscle following 
resistance training (Parente et al., 2008; Pansarasa et al., 2009). If so, this suggests that 
overload training causes an increase in the packing of contractile material within the 
muscle fibre (Penman, 1970). However, other investigations have reported no change in 
the specific tension of single human muscle fibres following resistance training (Trappe et 
al., 2000; Trappe et al., 2001a; Widrick et al., 2002), thus demonstrating the need for 
further clarification.  
 
 
Fig. 1.12 (Gilliver et al., 2009). Variation in the curvature of the force-velocity relationship and the 
consequences for power of human single muscle fibres. Values for force and velocity have been normalised 
for maximum isometric force (Po) and unloaded shortening velocity (Vmax). A, type I fibres; B, type IIA 
fibres. The darker lines are the mean values for the particular fibre type, the lighter lines indicate the range of 
values.  
 
The evidence of a resistance training-induced alteration in the human fibre-type profile is 
equivocal; some cross-sectional studies suggest that chronic strength training leads to a 
transition towards a faster fibre-type composition (D'Antona et al., 2006; Kesidis et al., 
2008), while longitudinal resistance training studies have shown either no change 
(Pansarasa et al., 2009) or a shift from type IIX to IIA MyHC expression and a transition 
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from IIx to IIa muscle fibre-type composition (Adams et al., 1993b; Roman et al., 1993; 
Fry et al., 1994; Staron et al., 1994; Campos et al., 2002). Therefore, further investigations 
are required to clarify the relationship between muscle fibre-type composition and the 
variance in strength and power observed in untrained human skeletal muscle, as well as the 
adaptation response of muscle to resistance training.  
 
Genetic predisposition  
Evidence from studies on human monozygotic and dizygotic twins suggests that 
heritability plays an important role in determining the phenotype in untrained muscle 
(Arden & Spector, 1997; Loos et al., 1997; Thomis et al., 1998b) and in the response to 
strength training (Thibault et al., 1986; Thomis et al., 1998a). Thus, it appears that a large 
proportion of the variability in muscle phenotypes in the untrained state, and in the 
response to strength training, might be attributed to genetic factors. The variants of two 
genes have received particular attention in recent years for their possible association with 
human muscle strength and size: the angiotensin I-converting enzyme (ACE) gene 
(Folland et al., 2000; Thomis et al., 2004; Williams et al., 2005; Pescatello et al., 2006; 
Charbonneau et al., 2008) and the alpha-actinin-3 (ACTN3) gene (Clarkson et al., 2005a; 
Clarkson et al., 2005b; Delmonico et al., 2007). The evidence for genotype-muscle 
phenotype and genotype-training response interactions is, however, inconclusive and more 
detailed work is required to appropriately determine the association between genotype and 
muscle force, PCSA and specific tension, and how the genotype affects the response to 
training.  
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Aims and objectives of the project  
Various factors have been discussed in this chapter that may individually or collectively 
provide an explanation for the inter-individual variability in untrained muscle strength, the 
disproportionate training-induced change in muscle strength and size and the variable 
response of human muscle to resistance training. The specific aims and objectives of the 
overall project were:  
 
1. To clarify the relationships between strength, muscle activation, muscle size and 
architecture in untrained individuals and to determine to what extent these factors 
explain the inter-individual variability in muscle strength. This is addressed in the work 
described in Chapter 2.  
2. To examine the effect of resistance training on the relationships outlined in Aim 1 and 
to assess to what extent changes in neural activation and muscle architecture explain 
the training-induced change in muscle strength and size. This topic is explored in the 
work described in Chapter 3.  
3. The third aim was to investigate possible explanations for an increase in specific 
tension as a result of training. Specifically, a change in fibre-type composition, 
augmented specific tension of single muscle fibres and evidence of an increase in 
lateral force transmission as potential reasons were examined in Chapter 4.  
4. To quantify the variation in human muscle responses to resistance training, regarding 
changes in muscle force, PCSA and specific tension. This is addressed in Chapter 5.  
5. To investigate possible associations between candidate gene polymorphisms and 
muscle size, strength and power, and how the different polymorphisms affect the 
response to resistance training. This topic is explored in the work described in Chapters 
6 and 7. 
  
 
 
Chapter 2 
The inter-individual 
variability in muscle strength 
 
 
 
 
 
 
Published as: 
Erskine RM, Jones DA, Maganaris CN & Degens H. (2009).  
In vivo specific tension of the human quadriceps femoris muscle.  
European Journal of Applied Physiology 106, 827-838.  
Chapter 2 The variability in muscle strength 
 
 
22 
Abstract  
It is not known to what extent the inter-individual variation in human muscle strength is 
explicable by differences in specific tension. To investigate this, a comprehensive 
approach was used to determine in vivo specific tension of the quadriceps femoris (QF) 
muscle (Method 1). Since this is a protracted technique, a simpler procedure was also 
developed to accurately estimate QF specific tension (Method 2). Method 1 comprised 
calculating patellar tendon force (Ft) in 27 young, untrained males, by correcting 
maximum voluntary contraction (MVC) for antagonist co-activation, voluntary activation 
and moment arm length. For each component muscle, the physiological cross-sectional 
area (PCSA) was calculated as volume divided by fascicle length during MVC. Dividing Ft 
by the sum of the four PCSAs (each multiplied by the cosine of its pennation angle during 
MVC) provided QF specific tension. Method 2 was a simplification of Method 1, where 
QF specific tension was estimated from a single anatomical CSA and vastus lateralis 
muscle geometry. Using Method 1, the variability in MVC (18%) and specific tension 
(16%) was similar. Specific tension from Method 1 (30 ± 5 N·cm-2) was similar to and 
correlated with that of Method 2 (29 ± 5 N·cm-2; R2 = 0.67; P < 0.05). In conclusion, most 
of the inter-individual variability in MVC torque remains largely unexplained. 
Furthermore, a simple method of estimating QF specific tension provided similar values to 
the comprehensive approach, thereby enabling accurate estimations of QF specific tension 
where time and resources are limited.  
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Introduction 
Muscle strength changes during growth, development and ageing and also as a result of 
training, disuse or disease (Degens et al., 1995; D'Antona et al., 2003; Elder et al., 2003; 
Payne et al., 2004; Reeves et al., 2004a; Stubbings et al., 2008). In addition, there is 
considerable variation in muscle strength between healthy, untrained individuals of similar 
age (Maughan et al., 1983; Chapman et al., 1984; Kanehisa et al., 1994; Williams et al., 
2005), part of which is due to differences in muscle size. However, some of the variation 
remains unexplained, implying differences in maximum force per unit cross sectional area 
of muscle between people.  
 
The primary determinant of the maximum force a muscle can generate is the number of 
sarcomeres in parallel, which is represented by the muscle’s physiological cross sectional 
area (PCSA). However, other extrinsic factors such as the level of voluntary muscle 
activation, antagonist muscle co-contraction, moment arm length, the angle at which the 
muscle fibres insert into the tendon and the infiltration of non-contractile material within 
the muscle may influence this relationship and thus the observed variance in strength.  
 
For animal muscle measured both in situ and in vitro, the specific tension (muscle force 
per PCSA) is in the region of 20-30 N·cm-2 (Close, 1969; Barany & Close, 1971; Lieber et 
al., 1986; de Haan et al., 1992; Degens et al., 1995) and for human single muscle fibres 
measured in vitro, specific tension values lie between 10 and 40 N·cm-2 (Degens et al., 
1999; Widrick et al., 2002; Cristea et al., 2008; Luden et al., 2008). However, for human 
muscle studied in vivo, the specific tension has been reported to range from 10 to 100 
N·cm-2 (Narici et al., 1988; Maganaris et al., 2001) and it is never clear whether such 
discrepancies represent intrinsic differences in muscle fibre contractility (such as variation 
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in muscle fibre type composition and/or myofibrillar density), are a function of variation in 
muscle structure or are the result of difficulties in accurately determining PCSA and/or 
muscle force. Human muscles can be characterised as either parallel- or pennate-fibred, i.e. 
the muscle fibres are predominantly arranged either in parallel or at an angle to the line of 
pull of the tendon. In parallel-fibred muscles, the anatomical CSA (ACSA) may provide an 
adequate estimation of the PCSA (Davies et al., 1988; Kawakami et al., 1994) but in 
pennate muscles, such as the quadriceps femoris muscle (QF), ACSA has been shown to 
underestimate PCSA (Alexander & Vernon, 1975; Wickiewicz et al., 1983). Using a 
combination of magnetic resonance imaging (MRI) and ultrasonography, it is possible to 
measure muscle volume and fascicle length in order to estimate the PCSA of human 
pennate muscles in vivo (Maganaris et al., 2001; Reeves et al., 2004a). To determine 
human muscle specific tension reliably in vivo, it is necessary to obtain maximal isometric 
muscle force at optimum fibre length, accounting for antagonist co-activation and 
voluntary activation of the agonist and to obtain accurate measurements of PCSA (Chow et 
al., 1999; Maganaris et al., 2001).  
 
Despite recent technological advances, no study has comprehensively accounted for all of 
the aforementioned extrinsic factors when assessing the specific tension of the human QF 
in vivo and thereby provided a more accurate representation of the inter-individual 
variance in the force-generating capacity of this muscle. The first aim of the present 
investigation was, therefore, to determine the specific tension of QF in vivo in a relatively 
large group of untrained individuals, taking into account the muscle architecture of each of 
the component muscles of the QF during MVC and other factors that affect force 
production. By doing so, it was hypothesised that the variation in QF specific tension 
would be much reduced compared to the variability in MVC torque. However, measuring 
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the geometry of all four component heads during MVC would require a great deal of time 
and effort from each participant. Alternatively, as the vastus lateralis muscle (VL) is the 
predominant of the four muscles (Alexander & Vernon, 1975; Wickiewicz et al., 1983; 
Scott et al., 1993), assessing VL geometry alone may provide an accurate estimate of the 
QF group as a whole, thereby saving time and resources. Although the VL has previously 
been considered representative of the total QF group (Trappe et al., 2001b; Reeves et al., 
2004a; Gorgey et al., 2006), accurate in vivo measurements of fascicle lengths and 
pennation angles of the four QF component muscles during MVC have yet to be reported 
and it remains to be seen whether the assumption that the VL is representative of the whole 
QF muscle is valid in this context. In addition, despite MRI currently being the most 
accurate and reliable method to measure muscle volume in vivo, it is a costly and time-
consuming process. However, a simpler alternative exists, whereby QF volume may be 
estimated from a single QF ACSA (Morse et al., 2007a). Therefore, the second aim of the 
study was to determine a minimal set of measurements that could be used to provide 
acceptable estimates of QF specific tension much more easily.  
 
Materials and methods 
Participants  
Twenty-seven untrained males, aged 21.3 ± 3.4 years, height 177.0 ± 5.8 cm, body mass 
76.2 ± 10.1 kg (mean ± SD), participated in the study after written informed consent was 
obtained. Participants were excluded if they had a history of lower-limb fracture, their age 
was outside the range of 18-39 years, they had taken part in strength training within the 12 
months prior to the study, had used dietary supplements or performance enhancing aids or if 
they were considered to be in ill health (assessed from the responses to a general health 
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questionnaire). The study was approved by Manchester Metropolitan University Local Ethics 
Committee.  
 
General experimental design 
Two different methods were used to calculate specific tension of the human QF and all 
measurements were performed on the right limb. Method 1 was the most detailed 
assessment of specific tension, where QF PCSA was calculated by accounting for the 
optimum fascicle length (Lf) and volume of each of the four constituent muscles. Patellar 
tendon force (Ft) was determined from MVC, accounting for antagonist muscle co-
activation, the level of voluntary muscle activation, patellar tendon moment arm (dPT) and 
optimum muscle fascicle pennation angle (θp). Method 2 was identical to Method 1, except 
that the VL muscle geometry at MVC was assumed to be representative of the mean QF 
architecture. Additionally, QF volume was estimated from a single ACSA and the femur 
length, as described by Morse et al. (2007a). Participants were asked to avoid performing 
any strenuous physical activity for up to 72 hours prior to partaking in two separate testing 
sessions within a 14-day period. The initial session was used to familiarise the participants 
with the test procedures and equipment and the reliability of the main measurements was 
determined from the test-retest results obtained from the two testing sessions. 
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Method 1 
Maximal voluntary isometric contractions  
Participants sat on a rigid chair of a dynamometer (Cybex Norm, Cybex International, New 
York, USA) with a hip angle of 85 degrees (180 degrees corresponding to supine position) 
and were firmly strapped at the hip, distal thigh and chest with inextensible straps to 
minimise movement. The seat length was adjusted for each participant to align the 
rotational axis of the dynamometer with the lateral femoral epicondyle. The lever arm of 
the dynamometer was firmly attached to the lower leg with inextensible straps and 
gravitational corrections were performed to account for the effect of leg and dynamometer 
lever arm weight on moment measurements. Participants were asked to perform a 
minimum of two MVCs (if the second attempt was >10% higher than the first, a third 
attempt was made to ensure a true MVC was achieved) at three separate knee joint angles 
(70, 80, and 90 degrees of knee flexion; 0 degrees equalling full extension). The order of 
joint angle was randomly selected and the angle at which the highest MVC occurred was 
deemed the optimum angle. Visual and verbal feedback was provided during and after 
each MVC, which lasted two-three seconds and there was a rest-interval of 60 seconds 
between each contraction. The range of joint angles investigated was based on results from 
a pilot study that indicated the optimum knee joint angle for this population was 80.5 ± 2.1 
degrees of knee flexion.  
 
Antagonist co-activation  
To determine the extent of antagonist (hamstring) muscle co-activation during a maximal 
voluntary isometric knee extension, the electromyographic (EMG) activity of the biceps 
femoris (long head) was recorded, as this muscle has previously been shown to be 
representative of the knee flexor muscle group (Kellis & Baltzopoulos, 1999). This 
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procedure has been reported in detail elsewhere (Reeves et al., 2004a). Briefly, once the 
biceps femoris muscle was identified and the skin surface impedance reduced to <5 kΩ, 
two bipolar silver chloride surface electrodes (Neuroline, Medicotest, Rugmarken, 
Denmark) were placed 20 mm apart along the sagittal axis over the muscle belly and one 
reference electrode was positioned over the lateral tibial condyle. The exact location of the 
electrodes was marked on the participant’s skin and recorded on an acetate sheet with a 
permanent marker to ensure precise electrode repositioning in the trial that followed the 
familiarisation session. The root mean square of the raw EMG signal was calculated over 
one second around the peak torque during each maximum voluntary isometric knee 
extension at all three joint angles. Maximal agonist EMG activity of the biceps femoris 
was recorded during isometric knee flexion at the same joint angles (Kellis & 
Baltzopoulos, 1997) and the torque produced by the hamstrings during knee extension was 
estimated assuming a linear relationship between torque and EMG activity (Reeves et al., 
2004a). The estimated antagonist torque obtained at the optimum knee extension joint 
angle was used to calculate the maximum overall knee extension torque.  
 
Voluntary muscle activation 
The procedure for determining maximal voluntary muscle activation using the interpolated 
twitch technique (ITT) has been described previously (Rutherford et al., 1986b; Williams 
et al., 2005). The participants were seated in the strength-testing chair as explained above. 
The level of voluntary activation was assessed with the knee joint fixed at 90 degrees of 
knee flexion. Electrical stimulation was administered via two 7.5 cm x 12.5 cm self-
adhesive electrodes (Versastim, Conmed, New York, USA), placed distally (anode) and 
proximally (cathode) over the QF. The QF was stimulated in a relaxed state with 100 mA 
pulses of 200 µs which were increased in 50 or 100 mA increments (Digitimer stimulator, 
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model DS7, Welwyn Garden City, UK) until no further increase in twitch torque was 
observed. This current was used two minutes later to elicit a single twitch whilst the 
participant was in the resting state, followed five seconds later by a second twitch during 
MVC. True maximal torque (TMT) was calculated as: 
TMT = MVCCORR / (1-t/T) 
where t is the amplitude of the superimposed twitch, T the value of the twitch before the 
MVC and MVCCORR the MVC corrected for co-activation. The percentage activation was 
given by: 
100 · (1-t/T) 
 
Torque signals, electrical stimuli, and EMG activity were displayed on a computer monitor 
(Macintosh, G4, Apple Computer, Cupertino, USA), interfaced with an acquisition system 
(AcqKnowledge, Biopac Systems, Santa Barbara, USA) used for analogue-to-digital 
conversion, at a sampling frequency of 2 KHz. The activation level estimated using the 
above approach depends not only on the voluntary effort applied during contraction but 
also on the stiffness of the series elastic component, which is a function of joint angle 
(Bampouras et al., 2006). However, no difference in QF voluntary activation or the rate of 
resting twitch torque development at knee flexion angles between 70-90 degrees was found 
in a subsample of seven participants from the same population (Table 2.1). Therefore, the 
level of activation at 90 degrees knee flexion was applied to the MVCCORR torque value at 
the optimum joint angle to determine TMT.  
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Table 2.1 Voluntary muscle activation capacity and rate of torque development (RTD) measured at 70, 80 
and 90 degrees knee joint flexion; n = 7; mean ± SD 
Knee flexion angle (deg) Voluntary activation (%) RTD (Nm⋅s-1) 
70 93.1 ± 2.2 861.3 ± 302.2 
80 94.2 ± 3.6 852.9 ± 257.9 
90 93.3 ± 2.5 859.0 ± 224.4 
 
Patellar tendon moment arm  
To calculate patellar tendon forces, the torque developed at the knee must be divided by 
the patellar tendon moment arm length (dPT). The procedure used to measure dPT has been 
described elsewhere (Tsaopoulos et al., 2006). Briefly, dPT was quantified using a 0.2-T 
magnetic resonance imaging (MRI) scanner (G-Scan, Esaote Biomedica, Genoa, Italy). 
Sagittal and coronal-plane knee scans were acquired using a Turbo 3D T1-weighted 
sequence with the following scanning parameters: time of repetition 40 ms; time to echo 
16 ms; matrix 256 x 256; field of view 180 mm x 180 mm; slice thickness 3.4 mm; 
interslice gap 0 mm. The knee was scanned at rest with the participant in the supine 
position and, due to the size of the coil, the joint had to be fully extended. The scans were 
imported to a dicom viewer (Osirix 2.7.5, Osirix Foundation, Geneva, Switzerland) and 
images in the coronal plane were used to identify the appropriate sagittal scans, which 
were used to locate the tibiofemoral contact point (TFCP, the midpoint of the shortest 
distance between the two femoral condyles and the tibia plateau). dPT was defined as the 
length of the perpendicular line between the axis of the patellar tendon and the TFCP 
(Tsaopoulos et al., 2006). Previously reported values of dPT length at full extension (0 
degrees knee flexion) and angles of 70, 80 and 90 degrees knee flexion (Baltzopoulos, 
1995) were used to provide the necessary ratios with which to estimate dPT length at 
optimum knee joint angle, i.e.  
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1. dPT 70 deg / dPT 0 deg = 1.08 
2. dPT 80 deg / dPT 0 deg = 1.03 
3. dPT 90 deg / dPT 0 deg = 0.99 
The appropriate ratio was applied to the dPT measured at full extension to provide the 
estimated dPT at optimum joint angle, which was subsequently multiplied by 1.14 to 
account for a 14% increase in dPT from rest to MVC (Tsaopoulos et al., 2007a).  
 
Muscle volume 
The upper leg was scanned using the same MRI protocol used to scan the knee, except that 
slice thickness was set at 2.8 mm. Contiguous axial ACSA scans were taken from the 
tibiofemoral joint to the iliac crest perpendicular to the femur, with the participant in the 
supine position. The scans were subsequently transferred to a computer and the ACSA of 
each of the four QF heads was manually outlined (Osirix 2.7.5, Osirix Foundation, 
Geneva, Switzerland) in ~15 scans at 3.08 cm intervals along the femur length (from the 
lateral tibiofemoral point of contact) and plotted against femur length (Fig. 2.1). 
Subsequently, a spline curve was fitted to the ACSA data points associated with each of 
the four component muscles (vastus lateralis, VL; vastus intermedius, VI; rectus femoris, 
RF; vastus medialis, VM) and muscle volume was calculated as the area under the curve, a 
technique that displays a strong test-retest reliability (Seynnes et al., 2008). MRI was 
performed prior to strength testing to ensure that volume measurements were not 
influenced by any exercise-induced fluid shifts.  
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Fig. 2.1 A typical plot illustrating how the volumes of the vastus lateralis (VL), vastus intermedius (VI), 
rectus femoris (RF) and vastus medialis (VM) muscles were calculated using Method 1. Anatomical cross-
sectional areas (ACSAs) of the four heads were measured every 3.08 cm along the femur length from the 
tibio-femoral condyle (X-axis origin) and plotted against femur length. A spline curve was then fitted to the 
points associated with each muscle and the muscle volume was calculated as the area under the curve  
 
Muscle architecture  
Muscle architecture was examined in the four constituent QF muscles via ultrasonography 
(MyLab25, Esaote, Genova, Italy) during MVC at optimum joint angle, with the 
participant seated in the strength-testing chair, as detailed above. While the participant was 
sitting at rest, the origin and insertion points and the lateral and medial boundaries of each 
muscle were identified using ultrasonography and the distances between the points were 
measured. Thus, four sites, each corresponding to 50% of the appropriate muscle length 
along the mid-sagittal plane of the muscle, were marked on the skin surface. A 10-15 MHz 
linear array probe was coated with a water-soluble transmission gel and positioned 
perpendicular to the skin surface on one of the measuring sites. The participant was then 
asked to perform an isometric knee extension to MVC at the pre-determined optimum joint 
angle. Ultrasound scans were acquired at the appropriate depth and focus to optimise 
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image quality and sampling frequency, which was maintained at or above 28 Hz and each 
series of scans was recorded in Audio Video Interleave format. An external voltage trigger 
was used to synchronise the series of ultrasound scans with the acquisition system, so that 
the single ultrasound image corresponding to the maximal isometric knee extension torque 
could be identified and exported for subsequent analysis. This procedure was repeated for 
each of the remaining three component muscles. Measurements of muscle fascicle length 
(Lf) and pennation angle (θp) were performed on selected images using digitizing software 
(NIH ImageJ, version 1.39b, National Institutes of Health, Bethesda, USA). θp was 
measured as the angle between the muscle fascicular paths and their insertion into the deep 
aponeurosis. Lf was measured by tracing the fascicle echo from origin to insertion, taking 
into account any curvature along the fascicle length. If one end of the fascicle extended 
beyond the acquired ultrasound image, the fascicle length was estimated by extrapolating 
the superficial and lower aponeuroses as well as the fascicle (Fig. 2.2). For every 
ultrasound image obtained, θp and Lf were measured on at least three fascicular paths and 
the average of these measurements gave the θp and Lf for each muscle. In the case of the bi-
pennate RF muscle, only the lateral θp and Lf was analysed, assuming that the muscle 
architecture for the medial side was identical.  
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Fig. 2.2 A representative ultrasound image of the vastus lateralis muscle in the sagittal plane, highlighting the 
fascicular path, the fascicle pennation angle (θp) and the upper and lower aponeuroses 
 
To compare the architecture of each component muscle (VL, VI, RF and VM) with that of 
the QF muscle group as a whole, the Lf and θ p of each constituent muscle was multiplied 
by the ratio of its respective volume to total QF volume. The sum of these values 
represented the weighted mean QF Lf and θ p at optimum joint angle.  
 
Physiological cross-sectional area (PCSA) 
The PCSA of each of the four constituent muscles of the QF was calculated by dividing the 
component muscle volume by its respective optimum Lf. The total RF volume was divided 
by the lateral Lf. The complete QF PCSA was given by the sum of the PCSAs of the four 
constituent muscles.   
 
Specific tension 
The force transmitted from the muscle fibre to the tendon is reduced as a result of the fibre 
pennation angle. Consequently, a reduced PCSA (rPCSA) of the complete QF muscle was 
determined as the sum of the PCSAs of the four constituent muscles, each multiplied by 
the cosine of the appropriate θp, thus:   
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rPCSAQF =  PCSAi • cos θpi
i =1
n
∑  
where rPCSAQF is the total reduced physiological cross-sectional area of the quadriceps 
femoris muscle, PCSAi is the muscle PCSA of each of the four heads of the quadriceps 
femoris muscle and cos θpi is the cosine of the optimum fascicle pennation angle in each 
one of the four heads of the quadriceps femoris muscle. QF specific tension was then 
obtained as follows:  
QF specific tension = Ft / rPCSAQF 
where Ft is patellar tendon force (TMT divided by the patellar tendon moment arm length). 
 
Method 2 
Method 2 differed from Method 1 in that the QF volume was estimated from a single QF 
ACSA (Fig. 2.3). With the participant relaxed in the supine position, femur length was 
measured as the distance from the tibiofemoral point of contact to the proximal insertion of 
the VL muscle, which was identified via ultrasonography (MyLab25, Esaote, Genova, 
Italy). Oil-filled beads were attached to the skin at the measurement location 
(corresponding to 40% of femur length from the distal end), in order that the correct MRI 
scan could be easily identified (Fig. 2.3). The participant was scanned in the supine 
position and five serial axial slices were acquired around the position of the beads using a 
spin echo T1-weighted protocol with the following scanning parameters: time of repetition 
200 ms; time to echo 1.9 s; matrix 256 x 256; field of view 180 mm x 180 mm; slice 
thickness 5 mm; interslice gap 5 mm. QF volume was then estimated by using the ACSAs 
of the constituent QF muscles from a single slice taken at 40% of the femur length, 
together with a series of regression equations, as described in detail by Morse et al. 
(2007a). This technique has been shown to consistently underestimate QF volume by 551 
cm3 (Morse et al., 2007a). Therefore, once QF volume was assessed using this procedure, 
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551 cm3 was added to the QF volume of each participant to provide a more accurate 
estimation.  
 
 
Fig. 2.3 A typical transverse magnetic resonance imaging scan of the quadriceps femoris muscle at 40% 
femur length. The boundaries of the four component muscles: vastus lateralis (VL); vastus intermedius (VI); 
rectus femoris (RF); vastus medialis (VM) have been highlighted 
 
QF PCSA was calculated by dividing the estimated QF volume by the fascicle length (Lf) 
of the VL only (Fig. 2.2); VL Lf measured during MVC at optimum joint angle was 
assumed to be representative of the mean Lf for the entire QF. QF rPCSA was then 
calculated as:  
QF PCSA · cos θpVL 
where VL θp was assumed to be representative of the mean QF θp.  
QF specific tension was subsequently calculated as follows: 
QF specific tension = Ft / rPCSAQF 
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Statistics 
The test-retest reliability of the main assessments used in Method 1 and Method 2 was 
determined by calculating the respective coefficients of variation (CV) and intraclass 
correlation coefficients (ICC), which are presented in Table 2.2. In order to compare the 
inter-individual variability in MVC knee joint torque with that of QF specific tension, the 
single sample CV (100 · [standard deviation · mean-1]) was calculated for these variables. 
Linear regression analyses were performed to determine the relations between Method 1 
and Method 2 regarding QF PCSA and specific tension. Bland-Altman plots were made to 
demonstrate the level of agreement between Method 1 and Method 2 concerning the 
calculation of QF PCSA and specific tension. The standard error of the estimate (SEE) of 
the regression equation was assessed to determine the accuracy of the estimate of PCSA 
and specific tension using Method 2 compared to Method 1 and was calculated using the 
following equation, where SD is the standard deviation of the values for Method 2:  
SEE = SD ⋅ √(1-R2) 
The absolute value was then expressed as a percentage of the mean value of Method 1. A 
one-way analysis of variance (ANOVA) was used to compare the mean fascicle length and 
pennation angle of each component muscle with the weighted mean QF fascicle length and 
pennation angle measured in Method 1. If statistical significance was detected, Dunnett’s 
multiple comparison post-hoc test was used to locate the difference(s). Statistical 
significance was accepted when P < 0.05.  
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Table 2.2 Reliability of the main measurements and calculations used in Methods 1 and Method 2 
Variable Method 1 Method 2 
 CV (%) ICC CV (%) ICC 
MVC torque 3.92 0.95 M1 M1 
Voluntary Activation 2.61 0.73 M1 M1 
Antagonist co-activation 14.39 0.89 M1 M1 
Moment arm length 1.57 0.95 M1 M1 
Tendon force 3.99 0.92 M1 M1 
Femur length N/A N/A 1.69 0.86 
QF ACSA N/A N/A 1.12 0.99 
QF Volume 0.81 0.99 1.73 0.99 
θp (VL; VI; RF; VM) 5.1; 5.7; 5.8; 6.5 0.86; 0.97; 0.90; 0.94 M1 (VL) M1 (VL) 
Lf (VL; VI; RF; VM) 3.5; 4.0; 4.7; 5.4 0.92; 0.94; 0.87; 0.79 M1 (VL) M1 (VL) 
QF PCSA 5.76 0.93 5.00 0.90 
QF specific tension 8.79 0.74 9.11 0.69 
CV, coefficient of variation; ICC intraclass correlation coefficient; MVC, maximal voluntary contraction; 
QF, quadriceps femoris muscle; VL, vastus lateralis muscle; VI, vastus intermedius muscle; RF, rectus 
femoris muscle; VM, vastus medialis muscle; θp, fascicle pennation angle; Lf, fascicle length; PCSA, 
physiological cross-sectional area; M1, as for Method 1 
 
Results 
The mean values and associated degrees of variance for MVC torque, antagonist muscle 
co-activation, level of voluntary muscle activation, patellar tendon moment arm length and 
tendon force that were used in both Method 1 and Method 2 to calculate tendon force are 
presented in Table 2.3. The single sample coefficients of variation for MVC torque, 
specific tension (Method 1) and specific tension (Method 2) were 17.8%, 16.2% and 
16.5%, respectively.  
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Table 2.3 Variables used in the calculation of tendon force; n = 27; mean ± SD 
MVC (N·m) 264 ± 47 
Antagonist co-activation (%) 16.5 ± 8.6 
Voluntary activation (%) 92.8 ± 3.7 
dPT (cm) 4.8 ± 0.3 
Patellar tendon force (N) 6335 ± 957 
MVC, Maximal voluntary contraction; dPT, patellar tendon moment arm 
 
Table 2.4 provides information on the measured volume, ACSA and PCSA of each of the 
four constituent QF muscles and the value for the total QF. In addition, Lf and θp at the 
optimum joint angle are reported for each of the component muscles, together with the 
weighted mean QF value (accounting for the ratio of constituent muscle volume to total 
QF volume). The VL optimum Lf and θp did not differ from the weighted mean QF Lf and 
θp (P > 0.05; Table 2.4). Table 2.5 presents QF volume, PCSA and specific tension values 
obtained from the two methods.  
 
Table 2.4 Morphological characteristics of the vastus lateralis (VL), vastus intermedius (VI), rectus femoris 
(RF), vastus medialis (VM) and total quadriceps femoris muscle (QF); n = 27; Mean ± SD. * significantly 
different (P < 0.05) to weighted mean QF value (applicable to Lf and θp only) 
Variable VL VI RF VM QF 
Vm (cm3) 674 ± 123 580 ± 103 339 ± 61 461 ± 69 2054 ± 261 
ACSA (cm2) 18.3 ± 3.5 20.1 ± 3.2 4.0 ± 1.4 22.3 ± 3.2 64.7 ± 7.9 
Lf (cm) 9.1 ± 1.2 10.5 ± 1.7* 69.0 ± 1.4* 10.5 ± 1.3* 9.4 ± 7.0 
θp (°) 15.7 ± 2.4 12.7 ± 3.8* 27.9 ± 7.6* 22.9 ± 6.6* 18.5 ± 2.6 
PCSA (cm2) 75.1 ± 14.5 56.5 ± 13.7 49.8 ± 10.9 44.4 ± 6.4 224.9 ± 27.1 
Vm, Muscle volume; ACSA, anatomical cross-sectional area at 40% femur length; Lf, fascicle length; θp, 
fascicle pennation angle; PCSA, physiological cross-sectional area calculated according to Method 1  
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Table 2.5 Quadriceps femoris muscle (QF) volume, physiological cross-sectional area (PCSA) and specific 
tension calculated according to Method 1 and Method 2. Values are mean ± SD; n = 27 
Method QF Volume 
(cm3) 
QF PCSA 
(cm2) 
QF Specific tension 
(N⋅cm-2) 
1 2054 ± 261 226 ± 28 30.3 ± 4.9 
2 2117 ± 238 236 ± 34 29.1 ± 4.8 
 
QF volume estimated using Method 2 was significantly correlated with that measured 
using Method 1 (R2 = 0.90; P < 0.0001; Fig. 2.4). Likewise, PCSA estimated using Method 
2 correlated with that calculated using Method 1 (R2 = 0.59; P < 0.0001; SEE = 9.9%; Fig. 
2.5a). Bland–Altman analysis concerning QF PCSA demonstrated that the respective bias 
was -10.6 cm2 and the 95% limits of agreement were between 33.1 and 54.4 cm2 (Fig. 
2.6a).  
 
 
Fig. 2.4 The relationship between measured (Method 1) and estimated (Method 2) quadriceps femoris muscle 
volume; R2 = 0.90; P < 0.0001; SEE = 3.7%; n = 27 
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Fig. 2.5 The relationship between calculated (Method 1) and estimated (Method 2) quadriceps femoris 
muscle PCSA (A) and specific tension (B); SEE = 9.9% (A) and 9.1% (B); n = 27 
 
As shown in Fig. 2.5b, the specific tension values derived from Method 1 correlated 
significantly with the estimates obtained from Method 2 (R2 = 0.67 P < 0.0001; SEE = 
9.1%). Bland–Altman analysis demonstrated that the respective bias was 1.2 N⋅cm-2 and 
the 95% limits of agreement were between -4.6 and 6.9 N⋅cm-2 (Fig. 2.6b). Furthermore, 
Method 1 and Method 2 produced similar values regarding the inter-individual variability 
in QF volume, PCSA and specific tension (Table 2.5).  
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Fig. 2.6 Bland-Altman plots showing the bias (—) and 95% limits of agreement (---) between Method 1 and 
Method 2 regarding the calculation of quadriceps femoris muscle PCSA (A) and specific tension (B); n = 27 
 
Discussion 
The hypothesis of the present study was that much of the expected variability in MVC 
knee joint torque might be explained by variation in extrinsic factors that have not been 
routinely measured, such as differences in the architecture of the four component muscles 
in the quadriceps femoris muscle group (QF), voluntary muscle activation, antagonist 
muscle co-activation and patellar tendon moment arm length. Because the list of possible 
factors affecting the measured force is extensive, the second aim of the current 
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investigation was to determine a minimal set of measurements that may be used to provide 
reliable estimates of QF specific tension in vivo. In short, the results of Method 1 of the 
present investigation have shown that, in a relatively large and homogeneous group of 
participants, variation in these extrinsic factors explains little (~2%) of the variance in 
maximum isometric knee joint torque. As calculated using Method 1, the variability in QF 
specific tension is 16%, which is similar to that reported in animal muscle (Degens et al., 
1995). Further, the results of the present study suggest that reliable comparisons can be 
made on the basis of a comparatively small number of measurements of muscle strength 
and size.  
 
In order to calculate PCSA and specific tension accurately, muscle architecture and tendon 
force should be assessed during maximal activation at the optimum joint angle, i.e. when 
the muscle fibres are at optimum length for producing maximum force (Chow et al., 1999; 
Maganaris et al., 2001). The present study is the first to address this issue in the QF using 
purely in vivo measurements of fascicle length for each of the four heads at maximum 
activation (Method 1). The results demonstrate that there are differences in fascicle length 
and pennation angle between the four component muscles at MVC, although VL 
architecture did not differ from the mean QF architecture (Table 2.4). This suggests that, 
although there may be differences in architecture between QF component muscles, VL 
geometry measured during MVC at the optimum joint angle is typical of the QF muscle 
group as a whole.  
 
The complex geometry of the four QF constituent muscles makes the in vivo calculation of 
the respective PCSAs and subsequent QF specific tension in Method 1 of the present study 
a sedulous process that is probably not suitable for large cohorts or where frequent 
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repeated measurements are required. Examining the variability in strength in a given 
population requires a considerable sample size (Maughan et al., 1983; Kanehisa et al., 
1994; Bamman et al., 2000; Akima et al., 2001; Hubal et al., 2005) and thus the time 
available to perform extensive measurements on each individual is limited. Obtaining a 
single QF ACSA assessment, however, is relatively straightforward and previous studies 
have generally compared this measure of muscle size with MVC to evaluate the muscle 
size-strength relationship in vivo (Ikai & Fukunaga, 1970; Maughan et al., 1983; Chapman 
et al., 1984; Maughan et al., 1984; Kanehisa et al., 1994; Akima et al., 2001). However, 
ACSA underestimates the PCSA of pennate muscles and net joint torque does not give a 
true representation of the maximum force generated by the muscle. Therefore, ACSA and 
MVC may give a false indication of the muscle size-strength relationship and the nature of 
any training-induced changes (Kawakami et al., 1995).  
 
To circumvent some of the problems associated with making multiple measurements, a 
simpler method was employed in which QF muscle volume was calculated from a single 
ACSA and the geometry of the VL muscle was considered representative of the mean QF 
muscle architecture (Method 2). This method produced similar PCSA and specific tension 
values (236 cm2 and 29 N·cm-2, respectively) to the more comprehensive approach used in 
Method 1 (226 cm2 and 30 N·cm-2, respectively). In addition, the PCSA and specific 
tension values calculated using Method 2 were highly correlated with those obtained using 
Method 1 and the SEE for PCSA and specific tension estimated using Method 2 was 
relatively small at just 10 and 9%, respectively. The Bland-Altman plot in Fig. 2.6a 
indicates that Method 2 overestimated QF PCSA calculated using Method 1 by just 11 cm2 
(4%) and the limits of agreement are relatively small, suggesting that Method 2 provided 
similar estimates of QF PCSA to Method 1. The slight overestimation was due primarily to 
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an initial 3% overestimation of QF volume. Consequently, Method 2 underestimated the 
QF specific tension calculated with Method 1 by only 1 N·cm-2 (4%) with a small variation 
around this bias (Fig. 2.6b). It appears, therefore, that Methods 1 and 2 are well matched 
for calculating QF PCSA and specific tension.  
 
The fact that Method 1 and Method 2 yielded very similar specific tension values and 
neither method appreciably reduced the inter-individual variability observed in MVC 
torque suggests that most of the variability in specific tension is related to factors other 
than differences in moment arm length, muscle architecture, voluntary activation and/or 
antagonist co-activation. The implication is, therefore, that differences reside in the 
intrinsic force generating capacity of the muscle fibres themselves. Inter-individual 
differences in QF muscle fibre type composition may explain some of the variance in QF 
specific tension, as type II muscle fibres have been shown to be intrinsically stronger than 
type I fibres (Bottinelli et al., 1996). Another possible explanation for some of the 
variability in QF specific tension is a variable infiltration of non-contractile tissue, such as 
intramuscular fat and connective tissue (Kent-Braun et al., 2000; Holmback et al., 2002; 
Macaluso et al., 2002), which has been reported to constitute 6% of the total QF volume 
measured in vivo in young women (Macaluso et al., 2002). By not differentiating between 
intramuscular contractile and non-contractile material in the present study, the volume of 
muscle contractile material may have been slightly overestimated, which would have led to 
an overestimation of PCSA and an underestimation of specific tension. Furthermore, 
although the mean composition of intramuscular non-contractile material is relatively 
small in young individuals (Macaluso et al., 2002), the variation around the mean is 
comparatively high and different amounts of intramuscular non-contractile material 
between people may well affect the overall variability in muscle specific tension. In 
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addition, differences in connective tissue content between people may lead to inter-
individual differences in the degree of lateral transmission of force from muscle fibres to 
the tendon, which would also affect the variability in specific tension (Jones et al., 1989).  
 
The QF specific tension reported using Method 1 of the present study (30 N·cm-2) is 
slightly higher than that reported elsewhere for the same (Narici et al., 1992; Reeves et al., 
2004a; Gorgey et al., 2006) and other muscles, such as the soleus and tibialis anterior 
(Maganaris et al., 2001). As well as differences in muscle fibre-type composition between 
different muscle groups (Johnson et al., 1973), variations in electrical muscle stimulation 
protocols (more specifically the pulse duration or frequency of stimuli) used to generate a 
joint moment may partly explain the variability in specific tension values reported between 
some studies (Maganaris et al., 2001; Gorgey et al., 2006). In addition, voluntary muscle 
activation was determined using the ITT in the present study, while a combination of T2-
MRI and neuromuscular stimulation has been used for the same purpose in several other 
investigations (Adams et al., 1993a; Kendall et al., 2006). The latter method generally 
demonstrates a lower voluntary muscle activation capacity (~75%) than the ITT (~90%) 
and hence would lead to differences between studies when calculating muscle specific 
tension in vivo.  
 
Conclusions 
Specific tension of the human QF muscle has been calculated in vivo from the most 
comprehensive set of measurements to date (Method 1) and the results indicate that most 
of the inter-individual variance in MVC torque arises from factors other then differences in 
the structure and geometry of the muscle. Possibly linked to this observation is the fact that 
a simpler approach (Method 2) provided an accurate estimate of QF PCSA and QF specific 
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tension and may be useful where time and resources are limited. It should be noted that the 
conclusions from the present study are based on a relatively homogeneous population and 
the methods and conclusions may therefore need to be validated for other populations. 
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Abstract  
The present study investigated whether in vivo human quadriceps femoris (QF) muscle 
specific tension changed following strength training by comprehensively determining QF 
maximal force and physiological cross-sectional area (PCSA). Seventeen untrained men 
(20 ± 2 yrs) performed high-intensity leg-extension training 3 times a week for 9 weeks. 
Maximum tendon force (Ft) was calculated from maximum voluntary contraction (MVC) 
torque, corrected for agonist and antagonist muscle activation, and moment arm length 
(dPT) before and after training. QF PCSA was calculated as the sum of the four component 
muscle volumes, each divided by its fascicle length (Lf). Dividing Ft by the sum of the 
component muscle PCSAs, each multiplied by the cosine of the respective fascicle 
pennation angle (θp), provided QF specific tension. MVC torque and QF activation 
increased by 31% (P < 0.01) and 3% (P < 0.05), respectively, but there was no change in 
antagonist co-activation or dPT. Subsequently, Ft increased by 27% (P < 0.01). QF volume 
increased by 6% but Lf did not change in any of the component muscles, leading to a 6% 
increase in QF PCSA (P < 0.05). θp increased by 5% (P < 0.01) but only in the vastus 
lateralis muscle. Consequently, QF specific tension increased by 20% (P < 0.01). An 
increase in human muscle specific tension appears to be a real consequence of resistance 
training rather than being an artefact of measuring errors but the underlying cause of this 
phenomenon remains to be determined.  
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Introduction 
The maximum force generated by skeletal muscle is primarily determined by the number 
of sarcomeres arranged in parallel, which is represented by the physiological cross 
sectional area (PCSA) of the muscle (Close, 1972; Powell et al., 1984). Consequently, an 
increase in PCSA should be accompanied by a proportional increase in force generating 
capacity as is observed in experiments on animal muscle subjected to chronic overload 
(Degens et al., 1995; Hornberger & Farrar, 2004). In human muscle, however, resistance 
training is commonly reported to induce a proportionally larger increase in strength than 
muscle size (Ikai & Fukunaga, 1970; Moritani & deVries, 1979; Young et al., 1983; Jones 
& Rutherford, 1987; Davies et al., 1988; Narici et al., 1989; Narici et al., 1996b; Ferri et 
al., 2003). One possible explanation for this discrepancy between animal and human may 
be the difficulty of assessing maximum human muscle force and PCSA in situ, compared 
to the fewer experimental constraints encountered in animal models.  
 
As well as assessing neural drive to the muscle and antagonist muscle co-contraction, a 
thorough assessment of the peripheral factors affecting the force generating capacity of a 
muscle is critical in accurately estimating in vivo muscle specific tension (maximum 
muscle force per PCSA). These factors include muscle volume, optimum muscle fibre 
length, muscle fibre pennation angle (the angle of fibre insertion into the aponeurosis) and 
moment arm length (Maganaris et al., 2001; Reeves et al., 2004a; Erskine et al., 2009). 
Anatomical CSA (ACSA), the area of muscle perpendicular to the longitudinal axis of the 
limb, underestimates the PCSA of pennate-fibred muscles (Alexander & Vernon, 1975). 
Nevertheless, this measure has frequently been used to assess the effects of strength 
training on quadriceps femoris (QF) muscle size (Young et al., 1983; Jones & Rutherford, 
1987; Narici et al., 1989; Narici et al., 1996b; Ferri et al., 2003) since there are technical 
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difficulties in assessing in vivo PCSA of the total QF muscle group, which comprises four 
pennate muscles of different sizes and optimum architecture (Chow et al., 1999; Erskine et 
al., 2009).  
 
Although a training-induced increase in fibre pennation angle (Kawakami et al., 1995; 
Aagaard et al., 2001; Reeves et al., 2004a) is thought to allow more contractile material to 
be accommodated along a given tendon length, thereby increasing the PCSA and allowing 
greater force production (Gollnick et al., 1981; Aagaard et al., 2001), it simultaneously 
reduces the force exerted by the fibre that is resolved along the tendon (Alexander & 
Vernon, 1975; Narici et al., 1996a; Degens et al., 2009). This demonstrates the importance 
of considering changes in muscle architecture when determining the training-induced 
changes in muscle specific tension in vivo. 
 
In addition to changes in muscle architecture and volume (Aagaard et al., 2001; Reeves et 
al., 2004a; Kubo et al., 2006), neural adaptations to resistance training, such as an 
increased voluntary muscle activation (Scaglioni et al., 2002; Reeves et al., 2004a) and 
reduced co-activation of antagonist muscles (Carolan & Cafarelli, 1992; Hakkinen et al., 
1998; Hakkinen et al., 2000) can lead to a change in maximum voluntary contraction 
(MVC) torque following training. A failure to fully account for possible changes in muscle 
architecture, activation or co-activation with training may lead to erroneous conclusions of 
the effects of strength training on in vivo muscle specific tension. Consequently, the aim of 
the present study was to elucidate whether in vivo QF specific tension was affected by 
high-intensity resistance training using a comprehensive assessment of individual 
component muscle volume and architecture, degree of voluntary muscle activation, 
antagonist muscle co-activation and moment arm length. It was hypothesised that QF 
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specific tension would remain the same after strength training. Thus, previous reports of a 
disproportionate increase in muscle strength and size with strength training would be 
explicable by changes in factors that have not been routinely measured in the past.  
 
Materials and methods 
Participants  
Seventeen untrained males, aged 20.1 ± 2.3 years, height 176.9 ± 4.7 cm, body mass 76.1 ± 
10.1 kg (mean ± SD), participated in the study after written informed consent was 
obtained. Participants were excluded if they had a history of lower-limb fracture, their age 
was outside the range of 18-39 years, they had taken part in resistance training within the 12 
months prior to the study, had used dietary supplements or performance enhancing aids or if 
they were considered to be in ill health (assessed from the responses to a general health 
questionnaire). The study was approved by Manchester Metropolitan University Local Ethics 
Committee. All volunteers were familiarised with the test procedures and equipment within 
a 14-day period prior to starting the study and participants were asked to maintain their 
habitual dietary intake and level of physical activity over the course of the investigation. 
 
Experimental design 
All in vivo measurements used to calculate maximum patellar tendon force (including 
MVC at optimum knee joint angle, voluntary QF muscle activation, antagonist muscle co-
activation and patellar tendon moment arm), QF muscle physiological cross-sectional area 
[including muscle volume and fascicle length (Lf) measurements of each component QF 
muscle (VL, vastus lateralis; VI, vastus intermedialis; RF, rectus femoris; VM, vastus 
medialis)] and QF muscle specific tension [accounting for the fascicle pennation angle (θp) 
of each constituent QF muscle] of the right limb before and after resistance training have 
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been described in detail as per Method 1 in Chapter 2.  
 
Progressive resistance training 
The training programme comprised unilateral knee extension exercises performed three 
times a week for a period of nine weeks on the right leg. Thus, each participant performed 
a total of 27 sessions and each session lasted 10-15 min. At the start of each week, the 
single repetition maximum (1 RM) was determined on a standard leg-extension machine 
(Technogym SpA, Gambettola, Italy) and the training intensity was set relative to the 1 
RM. Therefore, the training load was increased progressively throughout the training 
period, according to the re-assessed 1 RM. Each training session consisted of a warm-up 
set of 10 repetitions at 40% of the 1 RM, followed by four sets of 10 repetitions at 80% of 
the 1 RM, with a 2 min rest period between each set. Each repetition required 
approximately one second to lift and one second to lower the load through a range of 110 
to 20º of knee flexion (0º = full extension). All training sessions were supervised and 
appropriate verbal encouragement was given throughout each session.  
 
Statistics 
The test-retest reliability (coefficient of variation, CV and intraclass correlation coefficient, 
ICC) of all the measurements used to calculate in vivo QF specific tension has been 
reported in Chapter 2 (Erskine et al., 2009). Paired samples Student’s t-tests were used to 
investigate pre- to post-training differences in MVC torque, voluntary muscle activation, 
antagonist muscle co-activation, optimum knee joint angle, patellar tendon moment arm 
length, maximum patellar tendon force, total QF volume and total QF PCSA. A two-factor 
within subjects ANOVA was used to investigate the effect of time (2 levels; pre- and post-
training) on QF component muscle (4 levels; VL, VI, RF and VM) for each of the 
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following variables: muscle volume, Lf, θp and PCSA. If a training effect was detected, 
paired samples Student’s t-tests were used to locate post-training changes in each muscle. 
Differences and effects were considered significant when P < 0.05. All data are presented 
as mean ± standard deviation (SD) unless otherwise stated.  
 
Results 
Maximum patellar tendon force 
After training, MVC knee joint torque increased by 30.8 ± 8.6 % (P < 0.01; Table 3.1) and 
QF voluntary activation capacity increased by 2.6 ± 4.6 % (P < 0.05; Table 3.1). However, 
there was no change in the level of antagonist muscle co-activation, optimum knee joint 
angle or dPT (Table 3.1). Correction of MVC torque for all of these factors gave the 
maximum patellar tendon force, which increased by 27.4 ± 10.5% (P < 0.01; Table 3.1).  
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Table 3.1 Variables used to calculate maximum patellar tendon force before and after training 
Variable Before training After training Change (%) 
MVC (N⋅m) 269 ± 50 350 ± 57 30.8 ± 8.6** 
Optimum knee angle (°) 81.2 ± 3.4 81.8 ± 4.2 0.8 ± 3.5 
Co-activation (%) 13.5 ± 3.2 13.2 ± 2.9 -1.7 ± 9.9 
Activation (%) 93.4 ± 3.0 96.0 ± 3.5 2.6 ± 4.6* 
dPT length (cm) 4.8 ± 0.3 4.8 ± 0.3 0.2 ± 2.0 
Ft (N) 6296 ± 988 8023 ± 826 27.4 ± 10.5** 
MVC Maximum voluntary contraction; dPT patellar tendon moment arm; Ft maximum patellar tendon force; 
n=17; *P < 0.05 and ** P < 0.01 significant training-induced change  
 
Muscle architecture  
Lf did not change in any of the four component QF muscles following the nine-week 
intensive training programme (Table 3.2). VL muscle θp increased by 5.1 ± 8.8% 
following the training period (P < 0.01; Table 3.2) but the small increases in θp of the 
remaining three heads did not reach statistical significance (Table 3.2).  
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Table 3.2 Muscle architecture assessed before and after training 
 Before training After training Change (%) 
VL Lf  8.8 ± 1.1 8.8 ± 1.2 0.3 ± 9.0 
VI Lf  10.3 ± 1.9 10.4 ± 1.6 1.7 ± 14.1 
RF Lf  7.2 ± 1.7 7.4 ± 1.9 1.6 ± 9.4 
VM Lf  10.3 ± 1.2 10.3 ± 1.3 0.6 ± 7.6 
VL θp  16.2 ± 2.4 16.9 ± 2.4 5.1 ± 8.8** 
VI θp 13.2 ± 3.2 13.8 ± 3.1 6.8 ± 17.9 
RF θp 26.5 ± 4.6 27.0 ± 4.2 2.5 ± 9.9 
VM θp 24.5 ± 6.8 24.9 ± 7.4 1.8 ± 8.3 
VL, vastus lateralis; VI, vastus intermedius; RF, rectus femoris; VM, vastus medialis; Lf fascicle length (cm); 
θp fascicle pennation angle (°); n = 17; **P < 0.01 significant training-induced change 
 
Muscle volume  
Volumes of the individual component QF muscles (VL, VI, RF and VM) before and after 
training are shown in Table 3.3. Training had a similar significant effect by increasing the 
volumes of all four muscles (P < 0.05), resulting in a 5.5 ± 2.6% increase in total QF 
muscle volume (P < 0.01).  
 
Physiological cross-sectional area and specific tension 
The PCSAs for the RF and VM muscles increased significantly by 8.1 ± 11.7% and 7.4 ± 
9.9% (P < 0.05), respectively and, although not reaching statistical significance, the VL 
and VI muscle PCSAs showed a tendency to increase by 4.4 ± 10.4% (P = 0.09) and 4.7 ± 
8.0% (P = 0.06), respectively (Table 3.3). As there was no interaction between training and 
component muscle PCSA, all four muscles appear to have responded similarly to training, 
leading to a 5.5 ± 5.8% increase in whole QF muscle PCSA (P < 0.05). Systematically 
assessing maximally activated QF muscle force and PCSA before and after training led to 
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a 20.1 ± 13.1% increase in QF specific tension (P < 0.01), from 29.5 ± 4.1 N·cm-2 before to 
35.5 ± 5.1 N·cm-2 after training.  
 
Table 3.3 Muscle volume and physiological cross-sectional area (PCSA) assessed before and after training 
 Before training After training Change (%) 
VL volume (cm3) 677 ± 94 704 ± 106 3.9 ± 3.2** 
VI volume (cm3) 586 ± 117 609 ± 118 4.0 ± 2.5** 
RF volume (cm3) 345 ± 56 375 ± 57 8.9 ± 5.4** 
VM volume (cm3) 466 ± 55 500 ± 57 7.4 ± 4.1** 
QF volume (cm3) 2074 ± 221 2188 ± 245 5.5 ± 2.6** 
VL PCSA (cm2) 78.1 ± 13.0 81.7 ± 16.4 4.4 ± 10.4 
VI PCSA (cm2) 58.5 ± 15.3 60.0 ± 14.7 4.7 ± 8.0 
RF PCSA (cm2) 49.6 ± 11.5 53.3 ± 12.2 8.1 ± 11.7* 
VM PCSA (cm2) 45.6 ± 5.1 49.0 ± 6.9 7.4 ± 9.9* 
QF PCSA (cm2) 231 ± 24 245 ± 34 5.5 ± 5.8* 
VL, vastus lateralis; VI, vastus intermedius; RF, rectus femoris; VM, vastus medialis; n = 17; *P < 0.05 and 
**P < 0.01 significant training-induced change 
 
Discussion 
The present study sought to explain the disproportionate change in human quadriceps 
femoris (QF) muscle strength and size that is often observed following resistance training. 
It was hypothesised that a training-induced gain in knee joint MVC torque would be 
explained by changes in factors that have not been routinely measured in the past, such as 
changes in volume and architecture of the four component muscles of the quadriceps 
femoris (QF) group, together with changes in voluntary QF muscle activation antagonist 
muscle co-activation and changes in the patellar tendon moment arm length, thus 
indicating no change in QF muscle specific tension. Contrary to this hypothesis, however, 
in vivo QF muscle specific tension was found to increase by 20% following nine weeks of 
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high-intensity resistance training.  
 
The 31% increase in MVC observed in the present study is comparable to that reported by 
others following a similar period of resistance training of the QF (Hakkinen et al., 1998; 
Seynnes et al., 2007). MVC torque, however, is not a measure of the force produced by a 
maximally activated muscle. By assessing the voluntary activation capacity of the agonist 
muscle, the co-activation of the antagonist muscles and the length of the moment arm, 
maximal muscle force can be estimated in vivo (Maganaris et al., 2001; Reeves et al., 
2004a; Erskine et al., 2009). It has been suggested that greater neural adaptations than 
muscle hypertrophy might be the main reason for the disproportionate changes in muscle 
strength and size following strength training (Moritani & deVries, 1979; Staron et al., 
1991; Staron et al., 1994). However, voluntary QF muscle activation in the present study 
increased by only 3%, which was similar to previous reports of increased muscle activation 
after resistance training (Scaglioni et al., 2002; Reeves et al., 2004a). Furthermore and in 
line with previous studies (Hortobagyi et al., 1996; Reeves et al., 2004a; Reeves et al., 
2005), there was no change in the level of antagonist muscle co-activation following 
strength training. Therefore, it would appear that neural adaptations played a minimal role 
in explaining the 31% increase in MVC torque. In addition, although patellar tendon 
moment arm length (dPT) changes as a function of knee joint angle (Baltzopoulos, 1995), 
no change in optimum joint angle was observed in the current investigation, thus dPT was 
not altered following training. Consequently, correcting MVC for voluntary muscle 
activation, antagonist muscle co-activation and dPT gave a 27% increase in the maximum 
patellar tendon force, demonstrating that training-induced changes in voluntary activation, 
co-activation and moment arm contributed little to the 31% increase in MVC torque.  
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As the force generating capacity of a muscle is thought to be primarily determined by the 
number of sarcomeres in parallel, which is represented in vivo by the muscle PCSA (Close, 
1972), muscle hypertrophy is the factor most likely to account for this increase in 
maximally activated force. By dividing the volume of each component muscle by its 
fascicle length, PCSA of the whole QF muscle was able to be determined before and after 
training in the present study, thus providing the critical measure of in vivo muscle 
hypertrophy. In line with previous reports (Aagaard et al., 2001; Reeves et al., 2004a; 
Kubo et al., 2006), whole QF volume increased by 6% and, as fascicle length did not 
change with training in any of the four component QF muscles, QF PCSA increased by 
6%, accordingly. However, this relatively small degree of muscle hypertrophy explained 
only 22% of the increase in maximum muscle force resolved at the tendon, suggesting that 
other training-induced adaptations played a larger role.  
 
Although an increase in fascicle pennation angle (θp) allows more contractile material to 
attach to the tendon (Gollnick et al., 1981; Aagaard et al., 2001), less of the muscle fibre 
force is simultaneously resolved along the tendon (Alexander & Vernon, 1975; Narici, 
1999; Degens et al., 2009). Thus, taking into account the change in θp in each of the four 
component QF muscles is likely to improve the estimate of the change in force produced 
by the actual QF muscle fibres. The small training-induced increases in θp of the 
constituent QF muscles only reached statistical significance in the VL muscle, which 
reflected a 6% increase in QF PCSA. However, such small increases in θp would have 
minimal limiting effects on the force resolved at the tendon, thereby not greatly affecting 
the change in QF specific tension observed in the present study.  
 
Contrary to the original hypothesis of the present study it was not possible to reconcile the 
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large increase in knee extension torque with the smaller increase in QF muscle volume by 
allowing for changes in fascicle length and pennation angle of the component muscles, 
together with training-induced changes in activation and co-activation or alterations in 
optimal knee angle and moment arm. Consequently, it is concluded that the training 
resulted in a real increase in specific tension of the QF muscle, which accounted for most 
of the increase in MVC observed in the present study. A study on an elderly human 
population found specific tension of the VL muscle to increase by 19% following 14 
weeks of resistance training (Reeves et al., 2004a). In this particular study, the force 
generated by the VL muscle was estimated by assigning the patellar tendon force 
according to the relative VL PCSA obtained from another study (Narici et al., 1992), 
assuming that the relative QF component muscle PCSAs would not be affected by age or 
training status. The current investigation demonstrated that all four constituent QF muscles 
did respond similarly to resistance training, although the relative component muscle 
PCSAs differed from those reported previously (Narici et al., 1992).  
 
The source of the increase in in vivo QF specific tension cannot be deduced from the 
present results but various possibilities exist. An increase in the packing density of 
myofilaments would cause an increase in specific tension of single human muscle fibres, 
which has recently been reported following resistance training (Parente et al., 2008; 
Pansarasa et al., 2009), although others have observed no such a change (Trappe et al., 
2000; Widrick et al., 2002). Furthermore, it is possible that a change in muscle fibre-type 
composition and/or preferential muscle fibre hypertrophy of type II fibres (Staron et al., 
1994; Campos et al., 2002) might affect the change in whole muscle specific tension, as 
single fibre specific tension has been shown to be fibre-type dependant in human muscle 
(Bottinelli et al., 1996; D'Antona et al., 2006; Pansarasa et al., 2009). Alternatively, one 
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possibility that has yet to be tested is that there may be a change in the type of attachment 
between the contractile muscle fibres and the surrounding connective tissue through which 
force is transmitted to tendons and bones. It has been suggested that if there were an 
increase in lateral force transmission from sarcomeres along the length of the fibre, rather 
than only from the end sarcomeres, there would be an increase in the isometric force 
generated by the muscle with little or no increase in the cross sectional area, thus 
increasing in vivo specific tension (Jones et al., 1989).  
 
Conclusion 
The results of the present study demonstrate that, by systematically accounting for factors 
such as changes in volume and architecture of the four component muscles of the QF 
muscle group, voluntary QF muscle activation, co-activation of the antagonist muscles and 
patellar tendon moment arm length, in vivo QF muscle specific tension increased following 
resistance training. The cause of this increase in specific tension remains unknown but 
future studies should investigate the potential influences of a change in muscle fibre-type 
composition or an increase in lateral force transmission to obtain a more complete 
overview of how human muscle responds to resistance exercise.  
 
  
 
 
Chapter 4 
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Abstract  
It is not known why in vivo muscle specific tension increases following resistance training 
in humans but changes in muscle fibre-type composition, single fibre specific tension or 
lateral force transmission might provide explanations. The latter would increase specific 
tension but decrease contraction velocity, thus not affecting maximum power per unit 
muscle volume (Wmax/Vm). In vivo muscle specific tension, Wmax and Vm were determined 
in m. quadriceps femoris of 42 young men, while myosin heavy chain (MyHC) isoform 
composition and single fibre specific tension of m. vastus lateralis was established in a 
sub-group (n = 17) before and after high-intensity leg-extension resistance training (3·wk-1 
for 9 wks). Following training, in vivo muscle specific tension increased by 17% but 
Wmax/Vm remained unaltered. There was no relationship between the training-induced 
decrease in MyHC IIX and the change in specific tension in vivo. Isolated single fibre 
specific tension did not change for either type I or type II fibres following training. To 
conclude, it does not appear as though a change in fibre-type composition can explain an 
increase in muscle specific tension observed in vivo. Furthermore, no support was found 
for a training-induced increase in myofibrillar protein density. However, no change in 
Wmax/Vm suggests that a change in lateral force transmission might explain this 
phenomenon.  
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Introduction 
A common observation with resistance training studies in humans is that muscle strength 
increases more than size (Ikai & Fukunaga, 1970; Moritani & deVries, 1979; Young et al., 
1983; Jones & Rutherford, 1987; Davies et al., 1988; Narici et al., 1989; Narici et al., 
1996b; Ferri et al., 2003), suggesting that the intrinsic force-generating capacity of the 
muscle increases as a result of progressive overload. By overcoming previous technical 
difficulties in assessing in vivo physiological cross-sectional area (PCSA) and maximum 
force of human pennate muscles, it has been shown that in vivo muscle specific tension 
(maximum force per unit PCSA) does increase in both young (Chapter 3) and older 
(Reeves et al., 2004a) individuals. However, the underlying cause for this increase is not 
known and it remains to be seen whether changes in the determinants of muscle fibre 
contractile properties, namely myosin heavy chain (MyHC) isoform composition, and/or 
the way in which force is transmitted from the muscle fibre to the tendon can account for a 
training-induced change in muscle specific tension.  
 
In the untrained human quadriceps femoris (QF) muscle there is evidence to suggest that 
the intrinsic strength of type II fibres is twice that of type I fibres (Young, 1984; Grindrod 
et al., 1987) and several investigations of single human muscle fibres have indicated that 
the specific tension of type II single fibres may well be higher than that of the slower type I 
fibres (Bottinelli et al., 1996; D'Antona et al., 2006; Pansarasa et al., 2009). A shift in 
muscle fibre-type composition towards an apparently stronger type II fibre-type might 
therefore explain why in vivo specific tension increases following resistance training. The 
chronically overloaded muscles of bodybuilders express a higher MyHC IIX isoform 
composition and a higher specific tension of type II single fibres compared to untrained 
controls (D'Antona et al., 2006). However, following significant increases in strength, 
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some longitudinal resistance training studies have reported a transition in fibre-type 
composition from the faster IIx to IIa fibre-type (Adams et al., 1993b; Staron et al., 1994; 
Andersen & Aagaard, 2000; Campos et al., 2002), while other investigators have observed 
no such change (Pansarasa et al., 2009). Therefore, it is unclear whether or not an increase 
in specific tension of human muscle can be explained by a change in muscle fibre-type 
composition following strength training. Furthermore, a training-induced increase in whole 
muscle specific tension may also be realised if the specific tension of individual fibres is 
increased, although it is equivocal whether this does (Parente et al., 2008; Pansarasa et al., 
2009) or does not (Trappe et al., 2000; Trappe et al., 2001a; Widrick et al., 2002) occur in 
isolated human muscle fibres.  
 
Muscle force is not solely transmitted along the axis of the muscle fibre but also laterally 
to the tendon via the matrix of connective tissue that encases muscle fibres (Street, 1983; 
Patel & Lieber, 1997) and intra-sarcolemmal protein complexes known as costameres 
(Danowski et al., 1992). An increase in collagen synthesis (Miller et al., 2005), as well as 
an increase in costameric proteins (Woolstenhulme et al., 2006; Kosek & Bamman, 2008), 
which occurs in human muscle as a result of resistance training might result in an increased 
number of attachments between the extra-cellular matrix and intermediate sarcomeres that 
would serve to effectively increase the number of parallel sarcomeres per PCSA while 
reducing the functional length of the muscle fibres (Jones et al., 1989). The consequence of 
this is that specific tension of the muscle fibres would increase, while the maximum 
shortening velocity would decrease. Since maximum muscle power (Wmax) is a product of 
force and contraction velocity, Wmax normalised to muscle volume (Vm) would be expected 
to remain unchanged in such circumstances (Jones et al., 1989).  
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Furthermore, Chapter 2 demonstrated that QF muscle specific tension in young healthy 
men can be reliably estimated in vivo using an assessment of QF Vm from a single 
anatomical CSA of the QF muscle, together with the fascicle length (Lf) and pennation 
angle (θp) of the VL muscle (Method 2) (Erskine et al., 2009). It remains to be seen, 
however, whether this method remains valid when compared to the more comprehensive 
method (Method 1) after strength training. The first aim of the present study was therefore 
to determine whether a minimal set of measurements could provide acceptable estimates of 
QF specific tension following resistance training. If so, the second aim was to determine 
whether an expected increase in human muscle specific tension following resistance 
training could be explained by changes in muscle MyHC isoform composition, single fibre 
specific tension and/or lateral force transmission, the latter being reflected by an unaltered 
Wmax/Vm. It was hypothesized that enhanced in vivo muscle specific tension following 
resistance training would be due to increased lateral transmission of force and that the 
increase in specific tension would not be accompanied by an increase in Wmax/Vm or 
expression of fast MyHC.  
 
Materials and methods 
Participants  
Forty-two untrained males, aged 20 ± 3 years, height 178 ± 6 cm, body mass 74 ± 9 kg 
(mean ± SD), participated in the present study after written informed consent was obtained. 
Participants were excluded if they had a history of lower-limb fracture, their age was outside 
the range of 18-39 years, had taken part in strength training within the 12 months prior to the 
study, had used dietary supplements or performance enhancing aids or if they were 
considered to be in ill health (assessed from the responses to a general health questionnaire). 
The study was approved by the local ethics committee at Manchester Metropolitan 
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University. Volunteers were familiarized with all the test procedures and equipment within 
a 14-day period prior to the baseline measurements and, as far as possible, testing and 
training sessions occurred at the same time of day for each participant. Furthermore, 
participants were asked to maintain their habitual dietary intake and level of physical 
activity over the course of the study.  
 
Experimental design 
In vivo specific tension of the right QF muscle was calculated in 42 individuals before and 
after 9 weeks of leg-extension resistance training using a method (Method 2) that has been 
validated against a more comprehensive method (Method 1) in the untrained state (Chapter 
2). To investigate whether Method 2 provided accurate estimates of QF specific tension 
post-training, the physiological cross-sectional area (PCSA) and specific tension values 
obtained using Method 2 were compared with those obtained from Method 1 in a sub-
sample (n = 17) of the current cohort before and after training (Fig. 4.1). Peak power 
(Wpeak) was determined during short, all-out sprints on an isokinetic cycle ergometer 
(Sargeant et al., 1981) in the total cohort (n = 42) prior to and following the nine weeks of 
training. Muscle biopsies were taken from the vastus lateralis (VL) muscle in a sub-sample 
(n = 17) of participants before and after training to determine changes in MyHC isoform 
composition and the specific tension of isolated single muscle fibres.  
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Fig. 4.1 The relationship between the comprehensive Method 1 and the simplified Method 2 regarding (A) 
QF muscle physiological cross-sectional area (PCSA) before (; R2 = 0.53; P < 0.01) and after (; R2 = 
0.72; P < 0.01) training and (B) QF muscle specific tension before (; R2 = 0.66; P < 0.01) and after (; R2 
= 0.53; P < 0.01) training; n = 17 
 
Progressive resistance training 
The strength training protocol for this study has been described in detail in Chapter 3.  
 
Maximum force  
The method used to calculate maximum patellar tendon force (Ft) has been described in 
detail as per Method 2 in Chapter 2.  
 
Physiological cross-sectional area  
The method used to calculate QF muscle physiological cross-sectional area (PCSA) has 
been described in detail as per Method 2 in Chapter 2.  
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In vivo specific tension  
The method used to calculate QF muscle specific tension has been described in detail as 
per Method 2 in Chapter 2.  
 
Power output  
Peak power output (Wpeak) of the lower right limb was determined using a modified 
isokinetic cycle ergometer (Lode Standard, The Netherlands), driven by a 2.24 kW motor 
through a variable speed gearbox and with strain gauges within the pedals (Sargeant et al., 
1981; Rutherford et al., 1986a; Beelen et al., 1994). Handlebar and saddle settings were 
individually adjusted and recorded for subsequent tests and toe-clips were used to secure 
the participant’s feet to the pedals. The test started with a 5 min warm-up at a pedal 
frequency of 90 revolutions per minute (RPM) and with the pedals connected to an 
external load of 60 W. The external cranks were then connected to the electric motor and 
the participant performed unloaded isokinetic sprints at five predetermined, randomly 
assigned pedal frequencies (50, 70, 90, 110 and 130 RPM), where the participant attempted 
(unsuccessfully) to accelerate the system by exerting maximal voluntary force during each 
revolution. Each sprint lasted for 6 s and was separated by a 5 min resting period. During 
the low-to-medium speed sprints (50-90 RPM), the participant was secured to the saddle of 
the ergometer with a non-extensible waist-strap to prevent movement from the seated 
position as a consequence of leg forces exceeding body mass. Pedal forces in the 
horizontal (x) and vertical (y) planes (relative to the pedal surface) were measured using 
strain gauges inserted in the pedal and the pedal angle (relative to the crank) and crank 
angle (0° = vertical position) was recorded using incremental encoders. The x and y pedal 
forces, together with the pedal and crank angles and the pedal frequency were continuously 
recorded at a rate of 140 samples per second. Although participants performed a two-
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legged sprint, Wpeak was calculated in the right (trained) limb only. The method used to 
calculate Wpeak has been adapted from a previous study that used a similar protocol (Beelen 
et al., 1994). The highest x and y forces, together with the corresponding pedal and crank 
angles, were used to calculate peak tangential force (Ftan) during each sprint, thus:  
Ftan (N) = (Fy ⋅ cos θped) - (Fx ⋅ sin θped) 
where Fy is the vertical force and Fx is the horizontal force exerted on the pedal; cos θped is 
the cosine of the pedal angle; sin θped is the sine of the pedal angle (Fig. 4.2).  
Tangential velocity (Vtan) was calculated as follows:  
Vtan (m⋅s-1) = 2pir ⋅ (RPM / 60) 
where r is the length of the crank (0.177 m).  
Peak power output (Wpeak) was subsequently calculated at each pedal frequency according 
to the following equation:  
Wpeak (W) = Ftan ⋅ Vtan 
The coefficient of variation for repeated measurements using this technique was 3.8%. 
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Fig. 4.2 The calculation of tangential force (Ftan) during each crank revolution [adapted from Beelen et al. 
(1994)]. The crank angle (θc) and pedal angle (θped) were continuously recorded throughout the test, as were 
the forces applied to the pedal in the vertical (Fy) and horizontal (Fx) planes, which were multiplied by the 
cosine and sine of θped, respectively, to provide Ftan. Thus, Ftan = (Fy⋅ cosθped) - (Fx⋅ sinθped)  
 
Muscle biopsies 
A muscle sample was obtained from the VL muscle of 17 of the original 42 participants 
before and after training. Following application of local anaesthetic, the biopsy was 
harvested with a conchotome (Dietrichson et al., 1980) mid-way between the knee and 
greater trochanter and immediately frozen in liquid nitrogen, then stored at -80°C until 
subsequent analyses.  
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Myosin heavy chain isoform composition  
A 10 µm cryostat section from each pre- and post-training muscle sample was obtained 
and processed in sodium dodecyl sulphate (SDS) sample buffer (Laemmli, 1970). 
Subsequently, 10 µl of denatured sample was analysed using SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). The stacking and running gels both contained 30% glycerol, 
as well as 4% and 6% polyacrylamide, respectively. The gels were run at 120 V for 27 
hours at 15°C. MyHC isoforms were identified using a silver stain plus kit (BioRad, 
Hercules, California, USA), according to manufacturers instructions, and the relative 
quantities of protein were determined by densitometry (The Discovery Series, Quantity 
One 1-D Analysis Software, BioRad Laboratories Inc., Hercules, USA). The coefficient of 
variation of repeated measurements using this technique was 2.9%.  
 
Specific tension of isolated single muscle fibres  
The experimental procedure and composition of the different solutions have been 
described in detail elsewhere (Degens et al., 1999; Gilliver et al., 2009). Briefly, on the 
day of the experiments muscle bundles were incubated for 20 min in a relaxing solution 
containing 1% TritonX-100 to ensure membrane permeabilisation. The bundle was then 
transferred to relax solution and single muscle fibres dissected and attached to a force 
transducer (Aurora 403A, Aurora Scientific Inc., Canada) and isotonic lever (Aurora 
312C) in the fibre test set-up (Aurora 400). The sarcomere length was set at 2.60 µm and 
fibre CSA (fCSA) was determined while the fibre was suspended in air, assuming a 
circular shape and correction was made for swelling. Before maximal activation in a 
solution with pCa 45, the fibre segment was transferred to a solution with less EGTA than 
the relax solution for at least 30 s. The maximum isometric force (Po) was recorded and 
fibres were excluded if the force declined before reaching a plateau or if the sarcomere 
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length had changed by > 0.1 µm. A total of 108 fibres fulfilled these criteria (59 before and 
49 fibres after training). Specific tension was calculated as Po divided by fCSA. At the end 
of the experiments, the fibre segments were dissolved in sample buffer (Laemmli, 1970) 
and stored at -800C until they were characterised for MyHC isoform composition by SDS-
PAGE (see above).  
 
Statistics 
The test-retest reliability (coefficient of variation, CV and intraclass correlation coefficient, 
ICC) of all the measurements used to calculate in vivo QF specific tension has been 
reported in Chapter 2 (Erskine et al., 2009). Paired samples Student’s t-tests were used to 
investigate pre- and post-training differences in all the variables included in Table 4.1. 
Independent t-tests were used to determine differences between the entire cohort (n = 42) 
and the sub-sample (n = 17) in all variables before and after training. Linear regression 
analyses established the correlation coefficient before and after training between Method 1 
and Method 2 regarding QF PCSA and specific tension, as well as between QF specific 
tension and MyHC IIX isoform composition, between Vm and Wmax and between Wmax/Vm 
and MyHC isoform composition. A repeated measures ANOVA was used to investigate 
pre and post-training differences in MyHC I, IIA and IIX isoform composition, as well as 
pre and post-training differences in Wpeak and Wpeak/Vm at all five pedal frequencies. If a 
training interaction was found, paired Student’s t-tests were used to identify the pre- to 
post-training difference(s) and Bonferroni multiple correction was applied where 
appropriate. A two-way ANOVA was used to determine differences in specific tension 
between fibres of different types and changes in response to training. Due to the small 
number of hybrid (I/IIA and IIa/IIX) and IIX MyHC fibres, these fibres were not included 
in the analysis and comparisons were limited to MyHC I and IIA fibres. Statistical 
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significance was accepted when P < 0.05. All data are presented as mean ± standard 
deviation (SD) unless otherwise stated. 
 
Results  
Muscle specific tension  
There was no difference between the total cohort (n = 42) and the sub-sample (n = 17) 
regarding any of the variables either before or after training (Table 4.1). The sub-sample is 
therefore considered representative of the entire cohort. As shown in Table 4.1, MVC 
torque increased by 27 ± 10% following training (P < 0.01). QF voluntary activation 
capacity increased by 3.5 ± 5.1% (P < 0.01), whereas the level of antagonist muscle co-
activation did not change significantly after training and, likewise, there was no change in 
the patellar tendon moment arm (dPT). Consequently, maximally activated muscle force 
increased by 23 ± 11% (P < 0.01). After training, QF volume (Vm) increased by 5.5 ± 3.5% 
(P < 0.01) but fascicle length (Lf) of the VL muscle did not change. As a result, QF PCSA 
also increased by 6.4 ± 4.5% (P < 0.01). VL muscle pennation angle (θp) increased by 13.0 
± 9.8% (P < 0.01) and having accounted for all these factors, a 17 ± 11% increase in QF 
specific tension was observed following training (P < 0.01).  
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Table 4.1 In vivo measured and calculated variables before and after training; mean ± SD 
 Total cohort (n = 42) Sub-sample (n = 17) 
Variable Before training After training Before training After training 
MVC (N·m) 248 ± 50 315 ± 64** 244 ± 55 315 ± 66** 
Co-activation (%) 13.9 ± 5.2 13.6 ± 5.2 13.8 ± 4.1 13.5 ± 4.0 
Activation (%) 92.9 ± 4.7 96.0 ± 3.9** 91.3 ± 5.1 94.9 ± 4.0** 
dPT length (cm) 4.7 ± 0.3 4.7 ± 0.3 4.7 ± 0.2 4.7 ± 0.2 
Ft (N) 5809 ± 1067 7152 ± 1386** 5896 ± 1151 7316 ± 1357** 
QF volume (cm3) 2084 ± 243 2200 ± 277** 2116 ± 257 2237 ± 309** 
VL Lf (cm) 8.9 ± 1.4 8.9 ± 1.4 9.1 ± 1.3 9.0 ± 1.5 
VL θp (º) 16.1 ± 2.3 18.0 ± 2.5** 16.0 ± 2.2 18.0 ± 2.4** 
QF PCSA (cm2) 238 ± 41 253 ± 43** 235 ± 35 252 ± 41* 
QF specific tension (N·cm-2) 25.9 ± 5.3 30.3 ± 6.7** 26.5 ± 5.4 30.8 ± 5.3** 
MVC maximal voluntary contraction torque; dPT patellar tendon moment arm; Ft maximum patellar tendon 
force; QF quadriceps femoris muscle; VL vastus lateralis muscle; Lf fascicle length; θp fascicle pennation 
angle; PCSA physiological cross-sectional area; *P < 0.05 and **P < 0.01 significantly different from 
baseline 
 
Myosin heavy chain isoform composition 
The proportion of type IIX MyHC decreased from 29 ± 15% to 19 ± 16% (P < 0.05) after 
training. Although this must necessarily be accompanied by an increase in at least one of 
the other MyHC isoforms, the increases in the proportions of MyHC I and MyHC IIA did 
not reach statistical significance (Fig. 4.3). Furthermore, MyHC IIX isoform composition 
did not correlate with QF specific tension either before or after training (P > 0.05).   
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Fig. 4.3 Myosin heavy chain (MyHC) isoform composition of the vastus lateralis muscle  before and  
after training; n = 17; values are mean ± SD; *significantly different from baseline (P < 0.05); inset 
illustrates SDS-PAGE gel separations, showing MyHC I, MyHC IIA and MyHC IIX bands from one 
participant before (Pre) and after (Post) 9 weeks of resistance training  
 
Specific tension in single muscle fibres  
Before training, 4 pure type IIX fibres were isolated from the pre-training biopsies but no 
such fibres were found after training, although 2 IIA/IIX hybrid fibres were isolated after 
training but none of this hybrid type was isolated before training. Furthermore, 3 I/IIA 
hybrid fibres were isolated before training, while 3 were isolated post-training. A two-way 
ANOVA revealed that there was no effect of training on the specific tension of single 
fibres (P > 0.05), nor did one fibre type change its specific tension more than the other (P 
> 0.05). In addition, there was no difference in specific tension between type I and type IIA 
fibres (P > 0.05).  
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Fig. 4.4 Specific tension (Po/fCSA) of skinned single vastus lateralis muscle fibres of myosin heavy chain 
(MyHC) isoform type I (n = 19 before training; n = 21 after training), IIA (n = 33 before training; n = 24 
after training), and all fibres combined (n = 59 before training; n = 49 after training);  before training;  
after training; values are mean ± SD 
 
Power output  
From the five pedal frequencies tested (50, 70, 90, 110 and 130 RPM), peak power output 
(Wpeak) was the highest (Wmax) at 110 RPM, both before and after training (Fig. 4.5A) and a 
5% increase (P < 0.05) in Wpeak was observed at this pedal frequency only (Fig. 4.5A). 
Wpeak normalised to muscle volume (Wpeak/Vm) did not change with training at any pedal 
frequency (P > 0.05; Fig. 4.5B). Furthermore, neither Wmax nor Wmax/Vm correlated with 
MyHC IIX isoform composition either before or after training (P > 0.05) and there were no 
relationships between the training-induced changes of these factors (P > 0.05).  
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Fig. 4.5 (A) Peak power output (Wpeak) and (B) Wpeak normalised to QF muscle volume (Wpeak/Vm) measured 
on an isokinetic cycle ergometer at 50, 70, 90, 110 and 130 revolutions per minute (RPM) before () and 
after () resistance training; n = 42; values are mean ± SD; *significant change from baseline (P < 0.05) 
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Discussion  
The current investigation confirms that in vivo human quadriceps femoris (QF) muscle 
specific tension increases following resistance training and it was hypothesized that this 
occurs as a consequence of increased lateral transmission of force from sarcomeres along 
the length of the fibre to the extracellular matrix and, ultimately, to the tendon. One 
prediction of this idea is that whilst specific tension would increase, the consequent 
shortening of the functional length of the fibre would decrease the maximal velocity of 
shortening and that, consequently, maximal power output per unit of muscle volume would 
be unchanged as a result of training. The results of the present study substantially support 
this idea. Although an increase in specific tension could possibly be related to an increased 
expression of fast MyHC, the decreased proportion of the fastest IIX MyHC found in the 
present study would, if anything, result in a decrease in specific tension.  
 
In vivo muscle specific tension  
The method used to calculate in vivo QF specific tension before and after strength training 
in the present study was based on an estimate of QF muscle volume from a single 
anatomical CSA of the QF muscle, together with the fascicle length (Lf) and pennation 
angle (θp) of the VL muscle (Method 2). This method has provided similar QF muscle 
specific tension values to those obtained using a more comprehensive approach (Method 
1), where the volume and optimum architecture of each component muscle of the QF 
muscle group was considered in a large cohort of untrained young men (Erskine et al., 
2009). By validating these two methods on a subgroup of 17 participants, the present study 
has demonstrated that Method 2 provides valid estimations of QF specific tension after 
resistance training as well as in the untrained state, which is largely because strength 
training affects the volume and architecture of all four component QF muscles to a similar 
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extent (Chapter 3). The advantage of using Method 2, however, is that much less time is 
required than when using the more exhaustive Method 1 and is therefore better suited for 
large-scale investigations. Similar to previous findings for young (Chapter 3) and elderly 
(Reeves et al., 2004a) individuals, the present study demonstrated that in vivo specific 
tension of the QF muscle increased by 17% following short-term resistance training. This 
increase occurred after accounting for changes in the extrinsic factors that affect the 
estimation of QF muscle PCSA and maximally activated muscle force.  
 
Changes in myosin heavy chain isoform composition and its impact on specific tension 
Based on a comparison of bodybuilders and control subjects, it has been suggested that 
strength training may cause a shift in fibre-type composition towards the reputedly 
stronger type II fibre-type (D'Antona et al., 2006). The present study, however, observed a 
decrease in MyHC IIX isoform composition, which is in accord with the findings of 
previous short-term resistance training investigations (Adams et al., 1993b; Fry et al., 
1994; Staron et al., 1994; Andersen & Aagaard, 2000; Campos et al., 2002) and would 
thus be expected to result, if anything, in a reduction rather than an increase in specific 
tension. However, several studies, including the present study, have shown no differences 
in specific tension between fibre types of single human muscle fibres (Larsson & Moss, 
1993; Ottenheijm et al., 2005; Gilliver et al., 2009). Furthermore, any training-induced 
reduction in MyHC IIX might be outweighed by preferential hypertrophy of the type II 
fibres compared to type I fibres (Staron et al., 1994; Campos et al., 2002). It is therefore 
not surprising that no relationship was found between MyHC isoform composition and 
specific tension either before or after training, nor between the changes in MyHC 
composition and changes in specific tension in the current investigation. It seems unlikely, 
therefore, that changes in fibre type composition underlie the increase in specific tension 
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seen with training in the present study.  
 
Specific tension of isolated single fibres and the effect of resistance training 
A training-induced increase in muscle specific tension observed in vivo could conceivably 
occur due to augmented packing of contractile material (Penman, 1970). Such an increase 
would be reflected in an augmented specific tension at the single fibre level, which has 
been observed by some investigators (Parente et al., 2008; Pansarasa et al., 2009) but not 
others (Trappe et al., 2000; Trappe et al., 2001a; Widrick et al., 2002) following resistance 
training in human muscle. In accordance with the latter investigations, the present study 
observed no increase in specific tension of isolated single fibres from the vastus lateralis 
muscle. Although the reasons for this discrepancy are unclear, it may be that the disparity 
is related to the duration of the respective training programmes. In those investigations 
where a significant increase in single fibre specific tension was reported, participants were 
trained for a period of 12 months (Parente et al., 2008; Pansarasa et al., 2009). However, 
where no increase was observed, individuals took part in a training programme that lasted 
for a duration of 12 weeks (Trappe et al., 2000; Trappe et al., 2001a; Widrick et al., 2002), 
while the participants of the present study performed high-intensity resistance training for 
nine weeks in total. Whatever the explanation for the contrasting results, it appears 
unlikely that the training-induced increase in muscle specific tension observed in vivo in 
young men in the present study was due to an increase in myofibrillar protein density, as 
this would have been manifested in an augmented specific tension at the single fibre level.  
 
Power output and its significance regarding specific tension 
The fact that QF specific tension increased by 17% while Wmax/Vm did not change with 
training implies a 17% slowing of the QF muscle, which could have occurred as a 
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consequence of a decrease in Lf and/or shortening velocity of the muscle. VL Lf, however, 
did not change with training. The decreased proportion of MyHC IIX isoform seen after 
training is expected to have some consequences for the maximum velocity of shortening 
and thus for Wmax of the QF muscle. Muscle fibres composed exclusively of the MyHC IIX 
isoform have faster contractile properties than either MyHC I or IIA isoforms (Larsson & 
Moss, 1993; Bottinelli et al., 1996; Bottinelli & Reggiani, 2000; D'Antona et al., 2006). It 
is possible, therefore, that the apparent slowing of the muscle and the moderate increase in 
Wmax compared to the increase in specific tension may be due to this change in MyHC 
expression. However, pure type IIX fibres are relatively uncommon in the VL muscle of 
untrained young men (Widrick et al., 2002; D'Antona et al., 2006; Yu et al., 2007) and it is 
likely that most of the MyHC IIX in the present study would have been present in hybrid 
type IIA/IIX fibres, which are more prevalent than type IIX fibres (Klitgaard et al., 1990; 
Larsson & Moss, 1993; Widrick et al., 2002) and the difference in contractile velocity 
between type IIA/IIX and the type IIA fibres is less than it is between type IIX and IIA 
fibres (Bottinelli et al., 1994; Widrick et al., 2002; D'Antona et al., 2006; Yu et al., 2007). 
In addition, there was no relationship between either Wmax or Wmax/Vm and MyHC isoform 
composition before or after training, or between the training-induced changes in these 
variables. Consequently it seems unlikely that the change in MyHC IIX isoform 
composition was responsible for a lack of change in Wmax/Vm.  
 
A slowing of the muscle is consistent with the development of additional lateral 
transmission of force from sarcomeres along the length of the fibres. Such a change would 
explain the increase in specific tension without an increase in Wmax/Vm (Jones et al., 1989). 
An increase in attachments between intermediate sarcomeres and the extracellular matrix 
might arise from an increase in collagen synthesis (Miller et al., 2005) and/or proteins that 
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constitute structural complexes known as costameres (Woolstenhulme et al., 2006; Kosek 
& Bamman, 2008), which have been shown to play a key role in the lateral transmission of 
muscle fibre force (Danowski et al., 1992). An increase in lateral force transmission would 
have increased the “effective PCSA” of the muscle, thus increasing specific tension by 
allowing the muscle to produce more force without the need for additional contractile 
material. However, the functional length of the muscle fibres would have been reduced, 
thus decreasing the maximum shortening velocity and preventing Wmax from increasing to 
the same extent as specific tension (Jones et al., 1989). It is acknowledged, however, that 
power output measured during the leg-extension phase on an isokinetic cycle ergometer is 
not necessarily generated only by the QF muscle group, as the hip extensors and calf 
muscles may also contribute, but it has previously been shown that power measured in this 
way is related to thigh volume (Sargeant et al., 1981) and it seems unlikely that the 
contribution of synergist muscles would decrease as a result of training to the extent that 
they exactly counteracted any increase in power of the QF muscle. 
 
Conclusions  
Following nine weeks of high-intensity resistance training, a 17% increase in in vivo 
muscle specific tension was observed, which was not explicable by the concomitant fast-
to-slow shift in MyHC isoform composition. However, a training-induced increase in 
lateral force transmission could account for the change in specific tension, as power output 
normalised to muscle volume was unaltered after training despite a marked increase in 
isometric strength.  
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Abstract  
Considerable variation exists in the response of human muscle to resistance training and 
there are numerous methods of adaptation. Therefore, the primary aim of this study was to 
quantify the range of responses concerning the training-induced change in muscle force 
(F), physiological cross-sectional area (PCSA) and specific tension (F/PCSA). Fifty-three 
untrained young men performed progressive leg-extension training 3 times a week for 9 
weeks. Maximum quadriceps femoris (QF) muscle F was determined from maximum 
voluntary contraction (MVC) torque, the level of voluntary muscle activation, antagonist 
muscle co-activation and patellar tendon moment arm length (dPT). QF muscle specific 
tension was established from F and measurements of muscle volume and architecture. 
MVC increased by 26 ± 11% (P < 0.0001; range: -1 – 52%), while F increased by 22 ± 
11% (P < 0.0001; range: -1 – 44%). PCSA increased by 6 ± 4% (P < 0.001; range: -3 – 
18%) and specific tension increased by 17 ± 11% (P < 0.0001; range: -5 – 39%). In 
conclusion, training-induced changes in muscle force and PCSA varied substantially, 
giving rise to a highly variable change in muscle specific tension. In searching for 
mechanisms underlying these responses, it is important that the complexity of muscle 
adaptation to strength training is clearly appreciated.  
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Introduction 
It is well established that resistance training induces gains in both strength and muscle size 
in humans. However, even in relatively small sample sizes, it is evident that inter-
individual variation exists in these changes (Jones & Rutherford, 1987; Narici et al., 
1996b; Seynnes et al., 2009). Most previous studies have focused on the mean muscle 
response to overload and the variability was assumed to be experimental error associated 
with the measurements made or variation in the commitment of the subjects. More 
recently, however, there has been an increasing awareness that the variable training 
response is a “real” phenomenon and understanding the reasons for it may give insights 
into the mechanisms controlling muscle growth and changes in strength. In addition there 
could be practical benefits in knowing who might or might not respond since training is an 
important aspect of sport and rehabilitation. Consequently there is considerable interest in 
determining whether variants of particular genes are associated with the way in which 
human muscle adapts to strength training (Folland et al., 2000; Clarkson et al., 2005a; 
Pescatello et al., 2006; Delmonico et al., 2007; Charbonneau et al., 2008; Bray et al., 
2009). However, for a genetic study to provide useful information it is necessary to first 
characterize the variability in response, since there are several ways in which a muscle may 
increase in strength. Broadly, a muscle may increase in quantity [defined as the 
physiological cross sectional area (PCSA)] or quality (characterized as specific tension; 
force per unit PCSA) and there may also be questions concerning muscle activation and 
the co-contraction of agonist and antagonist muscles, as well as muscle architecture.  
 
A large-scale investigation has reported substantial variability in the response to 12 weeks 
of unilateral resistance training of the elbow flexor muscle group in 243 young men (Hubal 
et al., 2005). Relative training-induced changes in strength varied between individuals 
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from 0% to 150% and from -24% to 149%, according to the maximum load lifted in one 
repetition (1 RM) and the maximum isometric voluntary contraction (MVC), respectively. 
Relative changes in muscle anatomical CSA, on the other hand, ranged from -3% to 56%. 
Thus, not only does the response to strength training vary considerably between 
individuals but the amount of variation appears to differ, according to the variable 
measured. Although a proportion of the gain in 1 RM will undoubtedly be due to an 
increase in muscle force, an unknown amount is likely to result from increased co-
ordination of additional muscles during training (Rutherford & Jones, 1986), and the 
acquisition of this skill might differ between people. Furthermore, MVC is not necessarily 
a true measure of the maximum isometric force produced by a fully activated muscle. To 
assess this in vivo, the ability of an individual to fully activate their muscle, as well as the 
level of antagonist muscle co-activation and the length of the moment arm are critical 
measurements (Maganaris et al., 2001; Reeves et al., 2004a; Erskine et al., 2009). 
Moreover, as most human skeletal muscles are pennate in that the muscle fibres are aligned 
at an angle to the line of pull of the tendon (Alexander & Vernon, 1975), the muscle PCSA 
is the most appropriate measure to provide an accurate assessment of training-induced 
muscle hypertrophy, as this parameter represents the total CSA of all the constituting fibres 
of a muscle at right-angles to their long axes, and is the main determinant of maximum 
muscle force (Close, 1972; Powell et al., 1984). Therefore, an accurate quantification of 
the full range of responses of human muscle to resistance training requires the force and 
PCSA of a maximally activated muscle or group of muscles to be determined, thus 
enabling the extent of variable change in muscle specific tension to be established.  
 
The aim of the present study was to quantify the range of human muscle responses to 
resistance training with regard to changes in QF muscle strength and size. In doing so, it 
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was expected that the inter-individual variability in strength changes following resistance 
training would be reduced by accounting for training-induced alterations in voluntary 
activation, antagonist muscle co-activation, muscle volume and architecture.  
 
Materials and methods 
Participants  
Potential participants were excluded if they had history of lower-limb fracture, their age was 
outside the range of 18-39 years, had taken part in strength training within the 12 months 
prior to the study, had used dietary supplements or performance enhancing aids or if they 
were considered to be in ill health (assessed from the responses to a general health 
questionnaire). The study was approved by the Manchester Metropolitan University local 
ethics committee. Fifty-three untrained males, aged 20 ± 3 years, height 178 ± 5 cm, body 
mass 77 ± 11 kg (mean ± SD), were eligible to participate in the study after written 
informed consent was obtained. Volunteers were familiarized with all test procedures and 
equipment within a 14-day period prior to the baseline measurements and, as far as 
possible, testing and training sessions occurred at the same time of day for each 
participant.  
 
Habitual physical activity level 
The habitual physical activity level (PAL) of each participant was assessed by questionnaire 
(Baecke et al., 1982) prior to commencing the nine-week training period. The overall PAL 
was scored using a scale from 1 to 5 points, where 1 was the least active, 3 was 
intermediate and 5 was extremely active. Participants were asked to maintain their PAL 
and habitual dietary intake over the course of the study. 
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Experimental design 
Maximum quadriceps femoris (QF) muscle force, physiological cross-sectional area 
(PCSA) and specific tension muscle were determined in previously untrained individuals, 
as described in detail using Method 2 in Chapter 2 (Erskine et al., 2009), before and after 
nine weeks of leg-extension resistance training (described in Chapter 3).  
 
Statistics 
The test-retest reliability (coefficient of variation and intraclass correlation coefficient) of 
all the measurements used to calculate QF specific tension has been reported previously 
(Erskine et al., 2009). Post-training differences in MVC, co-activation, voluntary 
activation, maximum force, muscle volume, muscle fascicle length, muscle fascicle 
pennation angle, muscle PCSA and specific tension were analyzed using paired Student’s 
t-tests. Pearson correlations were used to determine relations between the changes in 
maximum force and specific tension and between the changes in PCSA and specific 
tension. Statistical significance was accepted when P < 0.05. All data are presented as 
mean ± standard deviation (SD) unless otherwise stated. The variable change in MVC, 
maximum force, PCSA and specific tension was reported for each parameter as the single 
sample CV [100 ⋅ (SD ⋅ mean-1)]. Individuals were defined as high or low responders to 
resistance training if their relative post-training changes were, respectively, ≥ 1 SD or ≤ 1 
SD.  
 
Results  
Habitual physical activity level  
The physical activity level (PAL) of the 53 participants prior to starting the strength-
training period was 2.7 ± 0.3 points, described as slightly less than “intermediate” in terms 
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of PAL scores (Baecke et al., 1982). PAL scores did not correlate with any of the muscle 
changes recorded after training.  
 
Single repetition maximum  
Following nine weeks of high-intensity unilateral leg-extension exercise, the 1 RM 
increased by 68 ± 30% (P < 0.001; Table 5.1), with individual changes ranging from 18 to 
113%.  
 
Table 5.1 Measured and calculated variables before and after training; n = 53; mean ± SD 
Variable Before training Post training 
1 RM (kg) 54.3 ± 10.9 88.2 ± 12.0* 
MVC (N·m) 246 ± 51 310 ± 62* 
Co-activation (%) 13.9 ± 4.9 13.6 ± 4.9 
Activation (%) 92.8 ± 5.2 96.2 ± 3.8* 
dPT length (cm) 4.8 ± 0.3 4.8 ± 0.3 
F (N) 5722 ± 1036 6968 ± 1343* 
Vm (cm3) 2080 ± 254 2201 ± 277* 
Lf (cm) 8.9 ± 1.3 8.9 ± 1.4 
θp (º) 16.1 ± 2.3 18.2 ± 2.9* 
PCSA (cm2) 237 ± 41 251 ± 43* 
Specific tension (N⋅cm-2) 25.6 ± 5.1 29.8 ± 6.4* 
MVC maximal voluntary contraction torque; dPT patellar tendon moment arm; F maximum muscle force; Vm 
quadriceps femoris muscle volume; Lf fascicle length; θp fascicle pennation angle; PCSA quadriceps femoris 
muscle physiological cross-sectional area; *P < 0.001 significantly different from baseline 
 
Maximum isometric QF force 
Maximum voluntary contraction (MVC) torque increased by 26 ± 11% (P < 0.001; Table 
5.1) and the full range of individual responses is shown in Fig. 5.1; the CV for the change 
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in MVC was 42%. Eight participants were designated high responders (≥ 1 SD) and 8 were 
classed as low responders (≤ 1 SD). QF voluntary activation increased by 3.8 ± 5.2% (P < 
0.001; range: -5 – 18%; Table 5.1), while antagonist muscle co-activation did not change 
significantly with training (range: -13 – 15%; Table 5.1). Similarly, dPT did not change 
with training (range: -4.8 – 4.4%; Table 5.1). Consequently, maximum isometric QF force 
increased by 22 ± 11% (P < 0.001; Table 5.1). The complete account of individual 
responses is shown in Fig. 5.2 (CV = 51%), from which it can be seen that 11 of the 
participants were high responders (of which only 5 were also high responders in relation to 
changes in MVC) and 10 were low responders (of which only 6 were also low responders 
concerning changes in MVC).  
 
Fig. 5.1 The range of individual changes in MVC relative to baseline values; dotted lines represent ± 1 SD 
from the mean (x¯), from which high responders (≥1 SD) and low responders (≤1 SD) were determined; n = 
53 
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Fig. 5.2 The range of individual changes in maximum muscle force relative to baseline values; dotted lines 
represent ± 1 SD from the mean (x¯), from which high responders (≥1 SD) and low responders (≤1 SD) were 
determined; n = 53 
 
Physiological cross-sectional area and specific tension 
Following training, QF muscle volume increased by 5.6 ± 3.4% (P < 0.001; range: 0 – 
16%; Table 5.1). Since VL muscle Lf did not change (range: -9 – 13%; Table 5.1), QF 
PCSA increased by 5.7 ± 4.5% (P < 0.001; Table 5.1) and the full range of responses is 
shown in Fig. 5.3 (CV = 75%), from which 8 individuals were defined as high responders 
and 8 were low responders. VL muscle θp increased by 13 ± 10% (P < 0.001; range: -5 – 
39%; Table 5.1) and when all these factors were taken into account, QF muscle specific 
tension increased by 16.5 ± 11.2% after training (P < 0.001; Table 5.1). The CV for the 
change in specific tension was 68% and all the individual changes are shown in Fig. 5.4, 
including the high (n = 9) and low (n = 12) responders. None of the PCSA low responders 
were classified as low responders according to change in force or specific tension, 
although interestingly, one was classed as a high responder regarding change in muscle 
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force. However, 75% of the low specific tension responders were also classified as low 
responders according to changes in muscle force. Regarding specific tension high 
responders, 89% were also high muscle force responders, of which only one was classified 
as a high responder regarding a change in PCSA. The discrepancy between high and low 
PCSA and specific tension response groups is supported by the lack of correlation between 
the training-induced changes in PCSA and maximum force (Fig. 5.5A), while the 
similarity between high and low force and specific tension response groups is supported by 
the strong relationship between the changes in specific tension and muscle force (Fig. 
5.5B).  
 
 
Fig. 5.3 The range of individual changes in muscle PCSA relative to baseline values; dotted lines represent ± 
1 SD from the mean (x¯), from which high responders (≥1 SD) and low responders (≤1 SD) were determined; 
n = 53 
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Fig. 5.4 The range of individual changes in muscle specific tension relative to baseline values; dotted lines 
represent ± 1 SD from the mean (x¯), from which high responders (≥1 SD) and low responders (≤1 SD) were 
determined; n = 53 
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Fig. 5.5 The change in muscle force as a function of the change in physiological cross-sectional area (PCSA); 
R2 = 0.02; P > 0.05 (A); and the change in muscle force as a function of the change in muscle specific 
tension; R2 = 0.76; P < 0.0001 (B); n = 53 
 
Discussion  
The present study is the first to quantify the complete range of responses of human muscle 
to resistance training, regarding changes in maximum force, PCSA and specific tension. 
The main conclusion is that the major variation in strength as a result of training is due to 
variations in the change in specific tension of the muscle.  
 
Since it has been suggested that prior training status affects the response to strength 
training (Kraemer et al., 2002), it might be assumed that the variable response to strength 
training observed in the present study was influenced by different levels of habitual 
physical activity (PAL) or training status prior to the commencement of training. However, 
as well as all participants being screened prior to taking part in the study (see Materials 
and methods) and their PAL reaching less than an intermediate score, training-induced 
changes in knee joint torque and muscle specific tension did not correlate with either 
baseline levels or PAL. Therefore, it is maintained that the range of responses to resistance 
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training observed in the present study in QF muscle specific tension is a real reflection of 
how the QF muscle responds to the particular type and intensity of resistance training 
performed in the current investigation.  
 
The present study observed a large variable change (CV = 45%) in the unilateral leg 
extension single repetition maximum (1 RM), which was similar to the previously reported 
variability (CV = 55%) in the unilateral preacher curl 1 RM in young men (Hubal et al., 
2005). Numerous resistance training studies in humans have used the 1 RM as a method of 
determining the effect of resistance training on muscle strength (Riechman et al., 2004; 
Hubal et al., 2005; Kostek et al., 2005; Hand et al., 2007; Charbonneau et al., 2008). 
However, although the 1 RM is a relatively simple task to perform, it involves not just the 
intrinsic strength of the muscle group but also the actions of synergistic and stabilizing 
muscles (Rutherford & Jones, 1986), thus questioning its suitability for detailed 
physiological assessment. In contrast, maximum voluntary isometric contraction (MVC) 
provides a more accurate assessment of muscle strength and the 26% increase in MVC 
knee extension torque observed in the present study is comparable to that found in 
previous investigations into the effects of training on the knee extensors (Rutherford et al., 
1986a; Jones & Rutherford, 1987; Narici et al., 1989) and other muscle groups (Cureton et 
al., 1988; Kawakami et al., 1995; Hubal et al., 2005). Great care was taken in the present 
study to ensure that the subjects were similar in their body size, age and habitual physical 
activity before training, that participant compliance was good and the training supervised 
by the same investigators throughout. Nevertheless, the range of training responses for 
MVC torque seen (CV = 42%) was large but somewhat less than that reported previously 
for the upper limb (CV = 107%) (Hubal et al., 2005). However, changes in MVC do not 
necessarily reflect changes in the contractile properties of the muscle itself, and for this it 
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is necessary to determine the true muscle force, taking into account changes in voluntary 
muscle activation, antagonist muscle co-activation and moment arm length (Maganaris et 
al., 2001; Reeves et al., 2004a; Erskine et al., 2009). Yet, rather than reducing the 
variation, taking these factors into account increased the variability of the training response 
(CV of 51% for muscle force versus 42% for MVC torque).  
 
As muscle force is primarily determined by the number of sarcomeres arranged in parallel, 
which is represented by the PCSA (Close, 1972; Powell et al., 1984), it is important to 
know how resistance training affects PCSA in order to ascertain a complete overview of 
the variable response of human muscle to overload. Previous studies have used whole 
muscle volume (Kanehisa et al., 2002; Charbonneau et al., 2008) or ACSA (Tracy et al., 
1999; Ferri et al., 2003; Hubal et al., 2005) to determine the effect of resistance training on 
muscle size. However, unlike PCSA, neither of these two indices of muscle size represents 
the CSA of the total number of fibres at right angles to their axes in pennate muscles. 
Although the mean increase in PCSA in the present study was relatively small (6%), it was 
evident that this change varied greatly between people (CV = 75%). Of the eight low 
hypertrophic responders in the present study, six exhibited no change or even a decrease in 
PCSA. In 89% of the participants, however, a varying degree of hypertrophy did occur and 
eight were classified as high responders, of which only two were also classified as high 
responders regarding a change in maximum force. Moreover, one of the low hypertrophic 
responders was in the high response group for change in maximum force.  
 
Change in muscle force did not correlate with the variable change in PCSA and it is 
evident therefore that while there is a variable hypertrophic response, this does not explain 
the variability in the force response to training. The lack of correlation between changes in 
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muscle PCSA and force is most probably due to inter-individual differences in the way 
muscle adapts to resistance training. For example, some people may have increased their 
strength through an increase in contractile material and therefore a proportional increase in 
muscle PCSA, while other may have increased the amount of force transmitted laterally, 
leading to larger increases in force than PCSA. However, it is acknowledged that certain 
assumptions were made in the calculation of in vivo muscle PCSA, which might have 
affected the lack of relationship between the changes in muscle force and PCSA after 
training.  Muscle PCSA was calculated by dividing muscle volume by fascicle length 
Muscle PCSA was calculated by dividing muscle volume by fascicle length (Haxton, 1944; 
Alexander & Vernon, 1975; Maganaris et al., 2001; Reeves et al., 2004a), with the latter 
measured during MVC in the mid-sagittal plane of the central portion of each muscle. 
Therefore, it was assumed that the muscle was cylindrical in shape and that its fascicles 
were a constant length. Although this assumption might be contested, previous in vivo 
(Narici et al., 1996a; Maganaris et al., 1998; Maganaris & Baltzopoulos, 1999) and 
cadaveric (Friederich & Brand, 1990) findings in human muscles support the assumption 
that fascicle length is relatively constant along the length of a muscle. Furthermore, this 
calculation of muscle PCSA does not account for a possible change in intramuscular fat 
content, myofibrillar packing or in muscle fibre-type composition. The first two 
possibilities could feasibly lead to an under or overestimation of muscle PCSA, which 
would lead to erroneous calculations of muscle specific tension. However, it has been 
shown that the level of non-contractile material in the muscle of young, healthy male 
individuals is relatively small (Holmback et al., 2002), while in Chapter 4 and in previous 
studies (Trappe et al., 2000; Trappe et al., 2001a; Widrick et al., 2002) it has been 
demonstrated that the specific tension of isolated single muscle fibres does not change 
following 9-12 weeks of resistance training, thus suggesting that there is no change in 
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myofibrillar packing following short-term strength training. Some investigations have 
provided evidence that single fibre specific tension is fibre-type dependent (Bottinelli et 
al., 1996; D'Antona et al., 2006; Pansarasa et al., 2009), thus leading to the possibility that 
a training-induced change in fibre-type composition might cause a change in the muscle 
force-size relationship. However, previous studies (Larsson & Moss, 1993; Ottenheijm et 
al., 2005; Gilliver et al., 2009) and the results from the study in Chapter 4 have suggested 
that there is no difference in isolated single fibre specific tension between fibre-types. 
Furthermore, Chapter 4 demonstrated no relationship between the training-induced 
changes in muscle specific tension and changes in myosin heavy chain isoform 
composition. Therefore, it is unlikely that a change in fibre-type composition would have 
influenced the lack of correlation between training-induced changes in muscle force and 
PCSA.  
 
Not surprisingly, in these circumstances the increase in force was found to correlate well 
with the increase in specific tension of the muscle but the cause of this varied increase in 
specific tension is not clear. A change in fibre-type expression appears to be an unlikely 
explanation since it has been shown in Chapter 4 of the current thesis, as well as in 
previous studies that strength training tends to decrease the expression of the fast IIX 
myosin isoform (Adams et al., 1993b; Roman et al., 1993; Fry et al., 1994; Staron et al., 
1994; Campos et al., 2002) and there appears to be no difference between the specific 
tension of type IIA and IIX fibres (Bottinelli et al., 1996; D'Antona et al., 2006; Pansarasa 
et al., 2009). Another possibility is that skeletal muscle in these individuals adapts by 
increasing its ability to transmit force laterally to the tendon. This increase might occur 
through an increase in attachments between intermediate sarcomeres and the extracellular 
matrix (Jones et al., 1989), either as a consequence of an increase in collagen synthesis 
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(Miller et al., 2005) or proteins that constitute structural complexes known as costameres 
(Woolstenhulme et al., 2006; Kosek & Bamman, 2008). The consequence of this is that the 
“effective” PCSA of the muscle would increase, thus allowing muscle force to increase 
without additional contractile material being required (Jones et al., 1989) although the 
effective length of the fibres would decrease and the power remain relatively constant 
(Chapter 4). 
 
Conclusions  
The results from the present study clearly demonstrate that the response of human muscle 
to high-intensity resistance training varies considerably between previously untrained 
young men. Large differences in the hypertrophic response of the muscle were not related 
to the variable response of muscle force, giving rise to variable increases in the specific 
tension of the muscle. In searching for mechanisms underlying these variable changes, 
whether of a genetic or other nature, future investigations should focus not only on factors 
involved in muscle growth but also those that affect the quality, or force generating 
capacity, of skeletal muscle.  
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Abstract  
It is equivocal whether angiotensin converting enzyme (ACE) and α-actinin-3 (ACTN3) 
genotypes are associated with human muscle strength, power and size, and the variable 
response to resistance training. To determine whether a detailed analysis of muscle 
phenotypes could resolve this issue, quadriceps femoris (QF) maximum muscle force, 
volume, physiological cross-sectional area (PCSA), specific tension (force per PCSA) and 
power output (Wmax) were determined before and after 9 weeks of leg-extension training in 
a large group of untrained young men genotyped for the ACE I/D and the ACTN3 R/X 
polymorphisms. Greater increases in the single repetition maximum (1 RM) and Wmax were 
observed in ACE I/I homozygotes compared to D-allele carriers. The ACTN3 R-allele was 
associated with greater 1 RM, muscle volume and Wmax but not with the response to 
training. To conclude, the ACE I/D polymorphism does explain a certain amount of the 
variability in the muscle response to strength training. The ACTN3 R/X polymorphism, on 
the other hand, explains part of the variability in muscle volume and power output but not 
the variable change in muscle power, strength or hypertrophy following resistance training. 
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Introduction 
Genetic factors appear to influence human muscle phenotype (Arden & Spector, 1997; 
Loos et al., 1997; Thomis et al., 1998b) and the response to strength training (Thibault et 
al., 1986; Thomis et al., 1998a). The identification of genes that are associated with muscle 
strength and the responses to resistance training would enhance our understanding of how 
human skeletal muscle adapts to loading and why some people are more prone to muscle 
wasting diseases or are more likely to attain elite athletic performance than others. The 
angiotensin I-converting enzyme (ACE) and the α-actinin-3 (ACTN3) genes have been 
considered prime candidates for such investigations.  
 
The primary role of ACE in the renin-angiotensin system is to convert angiotensin I (Ang 
I) to Ang II (Rigat et al., 1990). As well as causing vasoconstriction, Ang II also affects 
renal sodium reabsorption and aldosterone production. Moreover, the resulting Ang II also 
appears to regulate smooth (Geisterfer et al., 1988; Berk et al., 1989) and cardiac 
(Sadoshima et al., 1993; Ishigai et al., 1997) muscle growth. ACE is also expressed in 
skeletal muscle (Reneland & Lithell, 1994), where Ang II has been shown to modulate 
skeletal muscle hypertrophy in response to mechanical load (Gordon et al., 2001). 
Detection of either the presence (insertion allele, I) or absence (deletion allele, D) of a 287 
amino acid base pair fragment within intron 16 on chromosome 17 has enabled a 
functional polymorphism of the ACE gene to be identified in humans (Rigat et al., 1990). 
Accordingly, an individual can be classified as having one of three ACE genotypes; I/I, 
D/D, or I/D, where carriers of the D allele express higher ACE activity than I/I carriers 
(Rigat et al., 1990; Tiret et al., 1992; Danser et al., 1995; Williams et al., 2005; McCauley 
et al., 2009). Reports of a larger proportion of D-allele carriers among elite power athletes 
compared to endurance athletes and sedentary subjects has led to the hypothesis that 
Chapter 6 ACE and ACTN3 genotype and strength training 
 
 
104
carriers of the D-allele in the normal population would have larger muscle size and hence 
strength (Myerson et al., 1999; Nazarov et al., 2001; Woods et al., 2001).  
 
While significant associations have been found between ACE genotype and muscle size 
(Charbonneau et al., 2008) or strength (Williams et al., 2005) in untrained individuals, 
other investigators have observed no such association (Folland et al., 2000; Thomis et al., 
2004; Giaccaglia et al., 2008; McCauley et al., 2009). Similarly, some studies have not 
reported an association between the ACE genotype and strength gains (Thomis et al., 
2004; Williams et al., 2005; Pescatello et al., 2006), while those that did observe an 
association reported that carriers of the D allele had the greatest gains in strength (Folland 
et al., 2000; Giaccaglia et al., 2008). Although this could be caused by a greater 
hypertrophic response, there are no reports of ACE genotype specific muscle hypertrophy 
following resistance training (Thomis et al., 2004; Pescatello et al., 2006; Charbonneau et 
al., 2008).   
 
A common single nucleotide polymorphism (SNP) of the human ACTN3 gene results in 
either an arginine (R) or a stop codon (X) being located at amino acid 577 in exon 16 
(North & Beggs, 1996). Consequently, three ACTN3 genotypes exist; R/R, R/X, or X/X 
and, although the R577X genotype frequency varies between ethnic groups, the frequency 
for the X/X genotype in the human population is approximately 18% (Mills et al., 2001). 
Individuals homozygous for the X-allele (X/X genotype) are unable to produce ACTN3, a 
cytoskeletal protein found only in type II muscle fibres that binds and attaches actin 
filaments to the Z-line (Beggs et al., 1992; North et al., 1999; Mills et al., 2001). A 
deficiency in this protein might impair the performance of the type II fibres (MacArthur & 
North, 2007) that are able to contract faster and produce more power than type I muscle 
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fibres (Bottinelli et al., 1996; Widrick et al., 2002; Gilliver et al., 2009). Therefore, the 
ACTN3 R577X SNP is thought to be functionally significant in determining skeletal 
muscle strength and power, a hypothesis supported by an observed under-representation of 
X/X homozygotes among elite power athletes (Yang et al., 2003). Investigations into an 
association between ACTN3 genotype and untrained human muscle strength have 
produced conflicting results, with some investigators observing a positive relation 
(Clarkson et al., 2005a; Vincent et al., 2007), while others found no association 
(McCauley et al., 2009). Moreover, a positive association has been reported between the 
ACTN3 X/X genotype and changes in strength (Clarkson et al., 2005a), while another 
study found that the R/R genotype was associated with a greater change in power 
(Delmonico et al., 2007) following resistance training. However, no study to date has 
investigated the effects of ACTN3 genotype on maximally activated muscle force or 
muscle specific tension [maximum force per unit physiological cross-sectional area 
(PCSA)], or indeed the effects of resistance training on the above phenotypes. Such a 
detailed analysis of muscle phenotypes might provide novel information about the effects 
of ACTN3 genotype on inter-individual variability in muscle function and the variable 
response to overload training.  
 
The aims of the present study were to investigate the association of ACE and ACTN3 
genotypes with maximum QF muscle force, power, volume, PCSA and specific tension 
before and after resistance training in previously untrained men. It was hypothesized that 
the ACE D-allele would be associated with larger muscle volume, PCSA and maximum 
force before, and greater hypertrophy and strength gains following, resistance training. It 
was further hypothesized that the ACTN3 R-allele would be positively associated with 
higher strength and power values, as well as greater training responses in those variables. 
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Materials and methods 
Participants  
Potential participants were excluded if they had a history of lower-limb fracture, their age 
was outside the range of 18-39 years, had taken part in strength training within the 12 months 
prior to the study, had used dietary supplements or performance enhancing aids or if they 
were considered to be in ill health (assessed from the responses to a general health 
questionnaire). The study was approved by the Manchester Metropolitan University local 
ethics committee. Fifty-one untrained males, aged 20 ± 3 years, height 178 ± 5 cm, body 
mass 77 ± 11 kg (mean ± SD) participated in the present study after written informed 
consent was obtained. The characteristics of the participants according to ACE and 
ACTN3 genotypes are presented in Table 6.1 and Table 6.2, respectively. Volunteers were 
familiarized with all test procedures and equipment within a 14-day period prior to the 
baseline measurements and, as far as possible, testing and training sessions occurred at the 
same time of day for each participant. 
 
Habitual physical activity level 
The habitual physical activity level (PAL) of each participant was assessed by questionnaire 
(Baecke et al., 1982), as described in Chapter 5.  
 
Experimental design 
Maximum QF muscle force, volume, physiological cross-sectional area (PCSA) and 
specific tension were determined using Method 2 of Chapter 2, before and after nine weeks 
of high-intensity leg-extension resistance training (described in Chapter 3), in 51 
previously untrained men. Maximum power output (Wmax) of the right limb was 
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determined before and after training in a sub-sample (n = 40) at 110 RPM during maximal 
sprints on a modified isokinetic cycle ergometer, as described in detail in Chapter 4. In 
addition, all participants were genotyped for the ACE I/D and the ACTN3 R577X 
polymorphisms.  
 
Blood sampling  
A 10-mL blood sample was drawn from a superficial forearm vein and collected into 10-
mL EDTA tubes (BD Vacutainer Systems, Plymouth, UK). The blood was then aliquotted 
into 2-mL tubes (Eppendorf AG, Hamburg, Germany) and stored at -80°C until subsequent 
analysis.  
 
DNA extraction and determination of ACE and ACTN3 genotype  
DNA extraction was performed automatically using a QIAcube (Qiagen, Crawley, UK) 
and QIAamp DNA blood kit (Qiagen, Crawley, UK), following the QIAamp spin 
protocol for DNA purification from whole blood. Real-time quantitative polymerase chain 
reaction (Q-PCR) DNA amplification was performed to determine genotype of the ACE 
and ACTN3 genes.  
 
ACE I/D and ACTN3 genotyping: In each well of a 96-well plate, the 10-µL reaction 
volume included 5 µL Genotyping Master Mix (Applied Biosystems, Foster City, USA), 
4.3 µL nuclease-free H2O (Qiagen, Crawley, UK) and 0.5 µL genotyping assay mix. For 
the ACE I/D polymorphism, a three-primer system was used to eliminate mistyping 
(Shanmugam et al., 1993) that can occur with a two-primer system (Rigat et al., 1990). In 
this case, the 0.5 µL genotyping assay mix included the following primers: 5'-
CCCATCCTTTCTCCCATTTCTC-3'; 5'-AGCTGGAATAAAATTGGCGAAAC-3'; 5'-
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CCTCCCAAAGTGCTGGGATTA-3', and probes, VIC-5'-AGGCGTGATACAGTCA-3'-
MGB (I allele specific) and FAM-5'-TGCTGCCTATACAGTCA-3'-MGB (D allele 
specific) (Applied Biosystems, Foster City, USA). Regarding the ACTN3 R/X SNP, 0.5 
µL of TaqMan SNP genotyping assay mix (rs1815739) was used, which included the 
appropriate primers and TaqMan probes, VIC and FAM (Applied Biosystems, Foster 
City, USA). Subsequently, 0.2 µl DNA sample was pipetted into each well, except for two 
wells that served as negative controls, into which 0.2 µL nuclease-free H2O was pipetted. 
The well-plate was covered with an optical seal (Microseal ‘B’ adhesive seal, BioRad 
Laboratories, Hercules, USA) and centrifuged at 6000 x g (8000 RPM) for 1 min, then 
placed into a Q-PCR machine (Chromo4 Real-Time PCR Detection System, BioRad 
Laboratories, Hercules, USA). DNA amplification was then performed using the following 
PCR protocols. ACE I/D polymorphism: 50 cycles of incubation at 92°C for 15 s 
(denaturation) and annealing at 57°C for 1 min. ACTN3 SNP: denaturation at 95°C for 10 
min, followed by 40 cycles of incubation at 92°C for 15 s and annealing at 60°C for 1 min. 
ACE and ACTN3 genotypes were ultimately determined using Opticon Monitor 3.1 
software (BioRad Laboratories, Hercules, USA). All samples were analysed in duplicate 
and in all cases there was agreement between genotype for samples from the same subject. 
 
Statistics 
The test-retest reliability (coefficient of variation and intraclass correlation coefficient) of 
all the measurements used to calculate QF specific tension has been reported in Chapter 2 
(Erskine et al., 2009). ACE and ACTN3 genotype frequencies were tested for compliance 
with the Hardy-Weinberg principle using a χ2 test. To determine whether associations 
existed between ACE or ACTN3 genotype and 1RM, MVC, QF muscle force, power, QF 
PCSA and volume measurements before or after training, repeated measures analysis of 
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covariance (ANCOVA) was used. The within-subjects factor was time (2 levels: pre- and 
post-training) and the between subjects factor was ACE or ACTN3 genotype (3 levels: I/I; 
I/D; D/D or R/R; R/X; X/X). All ANCOVAs included either baseline QF muscle PCSA or 
BMI as covariates. All significant associations from the main ANCOVA model were 
subjected to pairwise statistical analyses among each of the three genotype groups (either 
I/I; I/D; D/D or R/R; R/X; X/X) with Bonferroni correction. In the case of QF muscle 
specific tension, repeated measures ANOVA with Scheffé post-hoc test was used. If a 
genotype x training interaction was found, a one-way ANOVA and Scheffé post-hoc test 
was used to detect genotype differences in the pre-training status and the training response. 
In addition, based on the hypothesis that ACE D-allele carriers would express higher 
baseline values and training-induced changes in muscle phenotypes than ACE I/I 
homozygotes, the results for ACE D/D and I/D genotypes were pooled and compared with 
those of I/I homozygotes. Likewise, the results for ACTN3 R/R and R/X genotypes were 
pooled and compared with those of ACTN3 X/X homozygotes. In this instance, the same 
statistical analyses were used as described above but the between-subjects factor had only 
2 levels (either ACE D-allele carrier and I/I genotype or ACTN3 R-allele carrier and X/X 
genotype). Statistical significance was accepted when P < 0.05. All data are presented as 
mean ± standard deviation (SD) unless otherwise stated. 
 
Results  
ACE and ACTN3 genotypes 
The ACE I/D genotype frequencies were 11.8%, 51.0%, and 37.3% for ACE I/I, I/D, and 
D/D, respectively (Table 6.1), and were in Hardy-Weinberg equilibrium (p = 0.373; q = 
0.627; χ2 = 0.418, P = 0.811). The ACTN3 genotype frequencies were 39.2%, 47.1%, and 
13.7% for R/R, R/X, and X/X, respectively (Table 6.2) and were also in Hardy-Weinberg 
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equilibrium for the investigated population (p = 0.628; q = 0.372; χ2 = 0.002, P = 0.999). 
Furthermore, the ACE and ACTN3 genotype frequencies for the sub-sample of individuals 
who completed the power output tests (n = 40) did not differ from the main group.  
 
Table 6.1 Physical characteristics and physical activity level (PAL) of participants according to angiotensin 
I-converting enzyme (ACE) genotype 
 ACE genotype  
Variable I/I  
(n = 6) 
I/D  
(n = 26) 
D/D  
(n = 19) 
I/D + D/D 
(n = 45) 
Age (years) 20.5 ± 2.1 19.8 ± 2.0 21.0 ± 4.4 20.3 ± 3.3 
Body mass (kg) 73.3 ± 12.1 76.2 ± 12.5 74.9 ± 7.2 75.7 ± 10.5 
Height (cm) 177.2 ± 7.2 178.6 ± 5.9 177.8 ± 5.1 178.3 ± 5.5 
BMI (kg·m-2) 23.3 ± 2.8 23.8 ± 2.9 23.7 ± 2.0 23.7 ± 2.6 
PAL 2.8 ± 0.5 2.7 ± 0.3 2.8 ± 0.3 2.7 ± 0.3 
I insertion allele; D deletion allele; BMI body mass index 
 
Table 6.2 Physical characteristics and physical activity level (PAL) of participants according to α-actinin-3 
(ACTN3) genotype  
 ACTN3 genotype  
Variable R/R 
(n = 20) 
R/X 
(n = 24) 
X/X 
(n = 7) 
R/R + R/X 
(n = 44) 
Age (years) 20.5 ± 2.4 20.7 ± 3.9 18.7 ± 1.1 20.6 ± 3.3 
Body mass (kg) 76.2 ± 6.5 76.5 ± 12.6 69.3 ± 12.2 76.3 ± 10.2 
Height (cm) 179.1 ± 4.8 178.1 ± 5.8 175.4 ± 7.4 178.6 ± 5.3 
BMI (kg·m-2) 23.8 ± 2.0 24.0 ± 2.9 22.5 ± 3.0 23.9 ± 2.4 
PAL 2.9 ± 0.4 2.7 ± 0.4 2.6 ± 0.2 2.8 ± 0.4 
R/R wild-type homozygote; R/X heterozygote; X/X mutant homozygote; BMI body mass index 
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Habitual physical activity level  
Physical activity levels (PAL) were not associated with either the ACE I/D or ACTN3 
R577X polymorphisms (Table 6.1; 6.2) and the mean PAL scores for each ACE and 
ACTN3 genotype are described as slightly less than “intermediate” (Baecke et al., 1982). 
Furthermore, PAL scores did not have a significant effect on any of the muscle changes as 
a result of training.  
 
Strength parameters before and after training 
Single repetition maximum (1 RM) There was not only a significant effect of training (P < 
0.05), but also a significant training x ACE genotype interaction (P < 0.05) on the 1 RM 
values that had been corrected for baseline muscle PCSA. Subsequent ANCOVAs revealed 
that the baseline 1 RM values were similar for all ACE genotypes but that the increase in 1 
RM was larger in I/I carriers than individuals of both I/D and D/D genotypes (Table 6.3). 
There was a significant effect of training (P < 0.001) and ACTN3 genotype (P < 0.05) 
regarding the 1 RM (Table 6.4). Ensuing ANCOVAs demonstrated that, while 1 RM 
values were not significantly different between ACTN3 genotype before training, both 
ACTN3 R/R and R/X genotypes had higher 1 RM values than X/X homozygotes following 
training (Table 6.4). As there was no training x ACTN3 genotype interaction (P > 0.05), 
individuals of all three genotypes responded similarly to training (Table 6.4). When 
ACTN3 R/R and R/X genotypes were pooled, it was found that the 1 RM (corrected for 
baseline muscle PCSA) was higher in carriers of the R-allele than in X/X homozygotes (P 
< 0.05; Table 6.4). 
 
Maximum isometric voluntary contraction MVC torque (corrected for baseline muscle 
PCSA) was independent of ACE genotype, both at baseline and following training (Table 
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6.3). The absence of training x genotype interaction for either ACE or ACTN3 genotype (P 
> 0.05) indicates that for each polymorphism, all three genotypes responded similarly to 
training (Table 6.3; 6.4). However, when ACTN3 R/R and R/X genotypes were pooled and 
compared with X/X genotype, a significant genotype effect was observed (P < 0.05), 
which was evident as a lower MVC in X/X than in the R carriers (Table 6.4).  
 
Maximum isometric force Once MVC torque had been adjusted to account for voluntary 
muscle activation level, antagonist muscle co-activation and moment arm length, and had 
been corrected for baseline QF PCSA, there was no difference between the genotypes of 
either the ACE or ACTN3 polymorphisms regarding baseline maximum QF muscle force 
and the training-induced increase in force (Table 6.3; 6.4).  
 
Muscle size before and after resistance training 
Muscle volume Having accounted for BMI, neither baseline muscle volume nor the 
training-induced changes in volume differed between ACE genotypes (Table 6.3). There 
was a significant effect of ACTN3 genotype (P < 0.01) on QF muscle volume (Table 6.4). 
Subsequent ANCOVAs revealed that QF muscle volume was higher in individuals of R/R 
genotype than X/X homozygotes before and after training (Table 6.4). As there was no 
training x genotype interaction (P > 0.05), individuals of all three genotypes responded 
similarly to training (Table 6.4). Furthermore, when R/R and R/X genotypes were pooled, 
carriers of the R-allele were found to have greater QF muscle volume than X/X 
homozygotes (P < 0.05; Table 6.4).  
 
Physiological cross-sectional area Dividing QF muscle volume by muscle fascicle length 
provides a measure of the physiological cross-sectional area (PCSA). No differences were 
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seen in the QF muscle PCSA between the ACE or ACTN3 genotypes, either before or after 
training, or in the training-induced increases in PCSA (Table 6.3; 6.4).  
 
Muscle specific tension before and after training  
Taking into account muscle fascicle pennation angle, maximum muscle force and PCSA, 
the specific tension of the QF muscle was found to be independent of ACE and ACTN3 
genotypes before and after training. Furthermore, QF muscle specific tension increased 
similarly between ACE and ACTN3 genotypes (Table 6.3; 6.4).  
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Table 6.3 Pre and post-training values, as well as training-induced changes in muscle strength and size 
phenotypes in participants according to angiotensin I-converting enzyme (ACE) genotype 
 ACE genotype    
Variable I/I 
(n = 6) 
I/D 
(n = 26) 
D/D 
(n = 19) 
I/D + D/D 
(n = 45) 
Pre 1 RM (kg) 47.0 ± 7.6 55.4 ± 11.3 54.7 ± 11.2 55.1 ± 11.1 
Post 1 RM (kg) 94.0 ± 4.2 89.2 ± 12.3 85.9 ± 12.8 87.9 ± 12.5 
∆ 1 RM (%) 103 ± 26* 65 ± 27 61 ± 31 63.2 ± 28.0 
Pre MVC (N·m) 227 ± 27 250 ± 56 251 ± 51 251 ± 54 
Post MVC (N·m) 272 ± 39 319 ± 64 312 ± 63 316 ± 63 
∆ MVC (%) 20.1 ± 10.8 28.5 ± 11.6 24.6 ± 8.7 26.9 ± 10.5 
Pre F (N) 5359 ± 983 5883 ± 1114 5669 ± 997 5793 ± 1060 
Post F (N) 6260 ± 1311 7245 ± 1355 6862 ± 1351 7083 ± 1351 
∆ F (%) 16.8 ± 11.8 23.5 ± 10.8 21.1 ± 11.2 22.5 ± 10.9 
Pre Vm (cm3) 2034 ± 279 2114 ± 279 2068 ± 221 2095 ± 254 
Post Vm (cm3) 2145 ± 248 2245 ± 315 2174 ± 230 2215 ± 281 
∆ Vm (%) 5.8 ± 3.5 6.1 ± 3.6 5.2 ± 3.1 5.7 ± 3.4 
Pre PCSA (cm2) 229 ± 33 239 ± 42 242 ± 42 241 ± 41 
Post PCSA (cm2) 239 ± 40 255 ± 44 254 ± 43 255 ± 43 
∆ PCSA (%) 3.9 ± 3.6 6.9 ± 5.0 5.0 ± 3.7 6.1 ± 4.6 
Pre ST (N·cm-2) 24.6 ± 4.8 26.1 ± 5.4 24.8 ± 5.1 25.6 ± 5.3 
Post ST (N·cm-2) 27.9 ± 6.5 30.5 ± 6.2 29.0 ± 6.8 29.9 ± 6.5 
∆ ST (%) 13.5 ± 12.7 17.3 ± 10.1 16.0 ± 12.6 16.8 ± 11.2 
I insertion allele; D deletion allele; 1 RM single repetition maximum (accounting for baseline muscle PCSA); 
MVC maximal voluntary contraction torque (accounting for baseline muscle PCSA); F maximum muscle 
force (accounting for baseline muscle PCSA); Vm quadriceps femoris muscle volume (accounting for BMI); 
PCSA quadriceps femoris muscle physiological cross-sectional area (accounting for BMI); ST quadriceps 
femoris muscle specific tension; all post-training changes were significantly different from baseline values (P 
< 0.05); *P < 0.05 significantly different from other genotypes 
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Table 6.4 Pre and post-training values, as well as training-induced changes in muscle strength and size 
phenotypes in participants according to α-actinin-3 (ACTN3) genotype  
 ACTN3 genotype  
Variable R/R  
(n = 20) 
R/X  
(n = 24) 
X/X  
(n = 7) 
R/R + R/X  
(n = 44) 
Pre 1 RM (kg) 55.3 ± 9.6 56.1 ± 12.5 45.7 ± 4.5 55.8 ± 11.2† 
Post 1 RM (kg) 92.5 ± 11.2† 88.9 ± 11.4† 77.1 ± 9.9 90.5 ± 11.3† 
∆ 1 RM (%) 70.7 ± 28.2 63.6 ± 31.9 71.0 ± 32.7 66.8 ± 30.1 
Pre MVC (N·m) 263 ± 54 246 ± 48 211 ± 40 253 ± 51† 
Post MVC (N·m) 321 ± 62 313 ± 62 273 ± 57 317 ± 61 
∆ MVC (%) 22.8 ± 10.8 28.0 ± 10.7 28.7 ± 9.8 25.6 ± 10.9 
Pre F (N) 5960 ± 1026 5674 ± 976 5351 ± 1370 5804 ± 998 
Post F (N) 6998 ± 1357 7053 ± 1290 6726 ± 1763 7028 ± 1306 
∆ F (%) 17.3 ± 10.9 24.5 ± 10.5 25.7 ± 10.6 21.2 ± 11.1 
Pre Vm (cm3) 2197 ± 244† 2053 ± 246 1895 ± 185 2118 ± 253† 
Post Vm (cm3) 2317 ± 268† 2183 ± 266 1974 ± 176 2244 ± 272† 
∆ Vm (%) 5.5 ± 3.9 6.4 ± 3.1 4.3 ± 2.6 5.9 ± 3.5 
Pre PCSA (cm2) 253 ± 47 229 ± 37 238 ± 40 240 ± 43 
Post PCSA (cm2) 267 ± 44 242 ± 45 250 ± 16 254 ± 46 
∆ PCSA (%) 6.1 ± 4.0 5.7 ± 5.3 5.6 ± 3.2 5.9 ± 4.7 
Pre ST (N·cm-2) 25.3 ± 6.0 26.1 ± 3.8 23.7 ± 6.8 25.7 ± 4.9 
Post ST (N·cm-2) 28.3 ± 7.2 31.1 ± 5.3 28.5 ± 7.7 29.8 ± 6.3 
∆ ST (%) 11.7 ± 12.1 19.0 ± 9.6 21.0 ± 10.5 15.7 ± 11.3 
R/R wild-type homozygote; R/X heterozygote; X/X mutant homozygote; Pre before training; Post after 
training; ∆ relative change after training; 1 RM single repetition maximum (accounting for baseline muscle 
PCSA); MVC maximal voluntary contraction torque (accounting for baseline muscle PCSA); F maximum 
muscle force (accounting for baseline muscle PCSA); Vm quadriceps femoris muscle volume (accounting for 
BMI); PCSA quadriceps femoris muscle physiological cross-sectional area (accounting for BMI); ST 
quadriceps femoris muscle specific tension; all post-training values were significantly different from baseline 
(P < 0.05); † P < 0.05 significantly different from X/X genotype 
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Power output and genotype  
There were no significant differences between the three ACE genotypes either before or 
after training regarding maximum power output (Wmax) corrected for BMI. However, ACE 
I/I homozygotes demonstrated a greater increase in Wmax compared to their D-allele 
counterparts (P < 0.05; Table 6.5). Regarding ACTN3 genotype, Wmax was higher in 
individuals of R/R genotype than X/X homozygotes before training, while after training 
both R/R and R/X genotypes expressed greater Wmax values than X/X homozygotes (P < 
0.05; Table 6.6). As there was no training x genotype interaction, individuals of all three 
genotypes responded similarly to training, although there was a small, non-significant 
increase in Wmax in the groups expressing the R-allele and a slight, non-significant decrease 
in the group expressing the X/X genotype (Table 6.6). When R/R and R/X genotypes were 
combined, carriers of the R-allele were found to generate more Wmax than X/X 
homozygotes (P < 0.05). Furthermore, the 16% higher Wmax observed in R-allele carriers 
(R/R + R/X) compared to X/X homozygotes before training was similar to the 20% larger 
baseline MVC values in R-allele carriers compared to individuals of the X/X genotype 
(Table 6.4; 6.6).  
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Table 6.5 Pre and post-training values, as well as training-induced changes in power output in participants 
according to angiotensin-I converting enzyme (ACE) genotype  
 ACE genotype  
Variable I/I  
(n = 4) 
I/D  
(n = 22) 
D/D  
(n = 14) 
D/D + I/D  
(n = 36) 
Pre Wmax (W) 1322 ± 227 1437 ± 210 1432 ± 185 1435 ± 198 
Post Wmax (W) 1531 ± 197 1471 ± 243 1472 ± 174 1472 ± 216 
∆ Wmax (%) 16.4 ± 5.9* 2.9 ± 12.3 3.5 ± 10.9 3.1 ± 11.6 
I/I homozygote; I/D heterozygote; D/D homozygote; Pre before training; Post after training; ∆ relative 
change after training; Wmax maximum power output; * P < 0.05 significantly different from D-allele carrier; 
values are mean ± SD 
 
Table 6.6 Pre and post-training values, as well as training-induced changes in power output in participants 
according to α-actinin-3 (ACTN3) genotype  
 ACTN3 genotype  
Variable R/R  
(n = 16) 
R/X  
(n = 19) 
X/X  
(n = 5) 
R/R + R/X  
(n = 35) 
Pre Wmax (W) 1478 ± 195* 1424 ± 198 1251 ± 158 1449 ± 19* 
Post Wmax (W) 1526 ± 151* 1513 ± 226 1190 ± 86 1519 ± 193* 
∆ Wmax (%) 4.1 ± 10.7 6.8 ± 11.8 -3.5 ± 14.3 5.6 ± 11.2 
R/R wild-type homozygote; R/X heterozygote; X/X mutant homozygote; Pre before training; Post after 
training; ∆ relative change after training; Wmax maximum power output; * P < 0.05 significantly different 
from X/X genotype; values are mean ± SD 
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Discussion  
It is controversial whether the ACE I/D and ACTN3 R/X polymorphisms are associated 
with human muscle strength, size and power, and the variable response to resistance 
training. This controversy might be related to the fact that inter-individual differences in 
strength and the variance in training-induced strength gains are not only influenced by 
muscle size but also the muscle specific tension (Chapter 5), a factor that is often 
overlooked. Therefore, the present study not only assessed muscle force and power but 
also muscle volume, PCSA and specific tension. It was hypothesised that the ACE D-allele 
would be related to higher baseline values of muscle size, strength and power, and greater 
training-induced gains in these phenotypes. Further, it was hypothesized that the ACTN3 
R-allele would be associated with greater values of baseline strength and power and greater 
training-induced gains compared to the X/X genotype. Contrary to what was hypothesised, 
ACE I/I genotype was associated with larger increases in dynamic strength and power 
compared to carriers of the ACE D-allele but as expected, the ACTN3 R-allele was 
associated with greater muscle volume and power output. However, there were no 
differences between any of the three ACE or ACTN3 genotypes regarding muscle specific 
tension, nor were there any differences in the training-induced changes in muscle force, 
volume or specific tension.  
 
A good indication of the maximum strength produced by a muscle is obtained from a 
maximum voluntary isometric contraction (MVC). In line with the reports of other 
investigations (Thomis et al., 2004; Pescatello et al., 2006; McCauley et al., 2009) there 
was no association between ACE genotype and MVC knee joint torque before training in 
the present study, although one previous study did observe higher MVC values in 
untrained D-allele carriers than in individuals of I/I genotype (Williams et al., 2005). 
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Furthermore, some investigators have reported no ACE genotype specific training-induced 
gains in MVC (Thomis et al., 2004; Williams et al., 2005), while others have reported an I-
allele dependent increase in isometric MVC following progressive resistance training 
(Pescatello et al., 2006). These apparent discrepancies might be related to the fact that 
MVC and changes thereof do not necessarily reflect changes in the force generating 
capacity of the muscle itself, which can be calculated by accounting for voluntary muscle 
activation, antagonist muscle co-activation and moment arm length (Maganaris et al., 
2001; Reeves et al., 2004a; Erskine et al., 2009). By excluding the possible bias of inter-
individual differences in voluntary activation, co-activation and moment arm length, the 
results from the present study suggest that ACE genotype does not play a major role in 
determining maximally activated muscle force or the extent to which resistance training 
affects muscle force production.  
 
D-allele carriers express greater ACE activity (Rigat et al., 1990; Tiret et al., 1992; Danser 
et al., 1995; Williams et al., 2005; McCauley et al., 2009) and ACE positively affects 
skeletal muscle hypertrophy by converting Ang I to Ang II (Gordon et al., 2001). 
Therefore, it is conceivable that D-allele carriers might have larger untrained muscles and 
be able to increase muscle size more than non-D allele carriers. Indeed, a previous study 
found D/D genotype carriers to have larger QF muscle volumes than their I/I counterparts 
(Charbonneau et al., 2008). Yet, the present study observed no association between ACE 
genotype and QF muscle PCSA or volume. Similar negative findings have been reported 
for ACE genotype and the anatomical CSA (ACSA) of the elbow flexor muscle group 
(Thomis et al., 2004; Pescatello et al., 2006).  
 
In contrast to expectation and other studies showing no association between ACE genotype 
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and 1 RM gains (Thomis et al., 2004; Pescatello et al., 2006; Charbonneau et al., 2008), 
the present study demonstrated that I/I homozygotes exhibited the largest gains in 1 RM. It 
should be noted that the 1 RM is a measurement of dynamic strength and may thus be a 
better index of muscle power than force. Indeed, the larger increase in 1 RM among ACE 
I/I genotype corresponded with the observation that I/I homozygotes increased their 
maximum power output more than ACE D-allele carriers. As power is the product of force 
x velocity and muscle volume is determined by the number of sarcomeres arranged both in 
series and parallel, it might be expected that I/I homozygotes increased their muscle 
volume more than D-allele carriers. However, neither the present investigation nor a 
previous study (Charbonneau et al., 2008) observed an ACE genotype specific hypertrophy 
response regarding QF muscle volume.  
 
This evidence indicates that the significance of the ACE I/D polymorphism in determining 
human skeletal muscle size and the extent of hypertrophy is minimal. Thus, the 
associations between ACE I/I genotype and a greater increase in 1 RM as well as 
maximum power output cannot be explained by muscle hypertrophy. Although the reasons 
for these unexpected findings cannot be inferred from the present results, training-induced 
changes in muscle fibre-type composition (Adams et al., 1993b; Roman et al., 1993; Fry et 
al., 1994; Staron et al., 1994; Campos et al., 2002) might offer a solution, as the force- and 
power-velocity relationships of isolated human muscle fibres are fibre-type dependent 
(Bottinelli et al., 1996; Gilliver et al., 2009).  
 
The maximum force of a muscle is primarily determined by the muscle PCSA and is, in 
pennate muscles, modulated to some extent by the fascicle pennation angle, as the force 
resolved at the tendon is reduced as a function of pennation angle (Alexander & Vernon, 
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1975; Degens et al., 2009). By accounting for these factors, it has been shown that in vivo 
specific tension of the QF muscle varies considerably between untrained individuals 
(Chapter 2), while Chapter 5 illustrated that substantial variation exists in the change in QF 
specific tension following resistance training. In the present study, no association was 
observed between ACE genotype and untrained muscle specific tension, or the training-
induced change in specific tension. Although the reasons for a lack of correspondence 
between ACE genotype and muscle PCSA, maximum force and specific tension are 
unclear, the theoretical physiological significance of genotype-dependent ACE activity in 
skeletal muscle is to modulate muscle size, rather than the intrinsic force of the muscle.  
 
A possible genetic association with muscle strength, power and size, and the variable 
response to resistance training, lies with the ACTN3 R/X SNP. The present study 
demonstrated that carriers of the ACTN3 R-allele performed higher MVC values than their 
X/X counterparts before training, suggesting that R-allele carriers are stronger than X/X 
homozygotes. However, this genotype dependence was lost after training and no 
association was observed with a training-induced change in MVC. A previous study made 
a similar observation concerning an ACTN3 R/X genotype association with isometric 
MVC of the elbow flexors in young women (Clarkson et al., 2005a). Therefore, the present 
study corrected MVC torque for the level of voluntary muscle activation, antagonist 
muscle co-activation and moment arm length to ascertain whether maximum muscle force 
was more strongly associated with ACTN3 genotype. However, there was no genotype 
association with maximum force, either before training, or with a training-induced change 
in force. The possibility remained that inter-individual differences or changes in muscle 
size and/or fibre pennation angle were obscuring any relation between ACTN3 genotype 
and muscle force. Therefore, maximum QF muscle force was corrected for muscle PCSA 
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and the angle of fibre pennation, in order to calculate the specific tension of the QF 
muscle. However, no ACTN3 genotype association was observed. This would suggest that 
the ACTN3 protein has little relevance in determining isometric muscle force.  
 
However, the possibility exists that ACTN3 allows greater force transmission at the Z line 
during high-velocity muscle contraction (Yang et al., 2003; MacArthur & North, 2004), 
thus enabling more force and ultimately more power to be produced during shortening 
contractions. Therefore, muscle function assessments that incorporate dynamic force or 
power generation would be more appropriate to detect an effect of ACTN3 genotype on 
muscle force or power. The present study observed greater 1 RM values in ACTN3 R-
allele carriers than in X/X homozygotes, but there was no genotype association with the 
training-induced increase in 1 RM. In contrast, a previous study found no association 
between ACTN3 genotype and 1 RM before or after strength training but contrary to 
expectation and to the results of the present study, a greater 1 RM training response was 
observed in female X/X homozygotes than in carriers homozygous for the R-allele 
(Clarkson et al., 2005a). However, the accuracy of the 1 RM assessment in determining the 
dynamic strength of a muscle group will undoubtedly be influenced by the level of muscle 
activation and the additional muscles involved in the exercise, such as the synergistic and 
stabilizing muscles (Rutherford & Jones, 1986). Thus, a certain proportion of the change in 
1 RM might be due to the development of skill involved in lifting weights rather than a 
change in muscle strength per se. Therefore, a more accurate assessment of power output 
would be required to support the 1 RM results of the present study.  
 
In line with the hypothesis of the current study, carriers of the ACTN3 R-allele were found 
to generate more power than X/X homozygotes both before and after strength training. 
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However, contrary to what was hypothesized, no association was observed between 
ACTN3 genotype and a training-induced change in power output. Conversely, a previous 
study on an older population (aged 50-85 years) found that while peak leg-extension power 
was higher in untrained X/X homozygotes than in carriers of the R-allele in females but 
not in males, both female and male carriers of the R-allele increased their peak power more 
than X/X homozygotes following leg-extension resistance training (Delmonico et al., 
2007). The reasons for the disparities between the results of the present study and those of 
other reports are not immediately clear, although differences in experimental 
methodologies and populations studied might have played a role.  
 
Muscle fibre CSA of ACTN3 deficient mice is significantly smaller compared to their 
wild-type counterparts that are able to produce the ACTN3 protein (Chan et al., 2008). If 
this were the case in human muscle, ACTN3 R-allele carriers would be expected to have 
larger muscles than X/X homozygotes and indeed QF muscle volume corrected for BMI 
was significantly greater in carriers of the R-allele both before and after training in the 
present study. Surprisingly, however, this difference was not observed in muscle PCSA, 
either before or after training. Furthermore, a previous study reported no association 
between elbow flexor muscle ACSA and ACTN3 genotype in either men or women 
(Clarkson et al., 2005a). Thus, it is possible that the larger muscle volume in R-allele 
carriers was due to these individuals having longer muscle fascicles than their X/X 
counterparts. Indeed, once corrected for BMI, there was a tendency (P = 0.09) for the 
fascicle length of the vastus lateralis muscle in R-allele carriers to be longer than that of 
X/X homozygotes before training (data not shown), while the association was stronger 
following training (P < 0.05). Therefore, the ~16% difference in power output between 
carriers of the R-allele and X/X homozygotes could be due to the ~12% larger muscle 
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volume in R-allele carriers compared to non R-allele carriers. This is further supported by 
the ~20% larger mean baseline MVC value in R-allele carriers compared to individuals of 
the X/X genotype.  
 
Conclusions 
The results from the present study demonstrate that ACE genotype is not associated with 
QF muscle volume, PCSA, maximum force or in vivo muscle specific tension prior to 
strength training. ACE I/I homozygotes, however, expressed larger increases in dynamic 
strength and power output after training. This indicates that the ACE I/D polymorphism 
does explain a certain amount of the variability in the muscle response to strength training, 
which is one of the major concerns of this thesis. Concerning the ACTN3 polymorphism, 
larger muscle volume, greater strength and power were found in carriers of the ACTN3 R-
allele compared to X/X homozygotes, although muscle specific tension was unrelated to 
ACTN3 genotype. No ACTN3 genotype differences were observed in the responses to 
resistance training and so it is unlikely that the variable response to resistance training is 
related to ACTN3 genotype. However, polymorphisms of genes encoding proteins 
involved in muscle cell structure may help explain the inter-individual differences in the 
intrinsic strength of skeletal muscle and the variable change in muscle specific tension. 
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Muscle strength and the effects of training have been of interest to man since mythological 
times when it is said that Milo of Croton first introduced the concept of progressive 
resistance training (Chiras, 2005). This idea of progressive muscle overload training was 
more recently developed by DeLorme and colleagues (Delorme, 1945; Delorme et al., 
1948; Delorme & Watkins, 1948; Delorme et al., 1950) and since then there has been a 
voluminous literature on the topic. However, one common and intriguing observation is 
that there are considerable differences between individuals in their muscular strength and 
also in their response to resistance training. In maximally activated parallel-fibred muscles, 
that is where the fibres are aligned parallel to the line of pull of the tendon and run from 
one end of the muscle to the other, the strength and power of the muscle are directly 
related to the cross sectional area and volume of the muscle, respectively. However, there 
are a host of other factors that modulate the contractile properties of the muscle in vivo and 
when it comes to training adaptations it is important that these are all considered when 
trying to explain the overall change in muscle function. This has been the main purpose of 
the work described in this thesis.  
 
The general aims of the current thesis were to investigate the differences in strength 
between untrained individuals and to perform a detailed examination of the response of 
human muscle to resistance training concerning gains in muscle strength and size and the 
extent to which these responses vary from person to person. Chapter 1 provides a review of 
the factors that could affect the strength of a muscle and how they might change with 
training. Chapter 2 focuses on investigations designed to explain the inter-individual 
variation in maximum voluntary isometric contraction (MVC) knee joint torque in a large 
homogenous cohort of young men by systematically accounting for a variety of 
neuromuscular parameters. The main conclusion was that the differences in MVC torque 
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could not be explained by variation in muscle volume, architecture (fascicle length and 
pennation angle), activation or moment arm length. The work described in Chapter 3 
examined the effect of overload training of the quadriceps femoris (QF) muscle with the 
aim of determining whether the gains in strength can be explained by an increase in size of 
the muscle or whether there is an increase in specific tension after taking into account the 
possible changes in muscle architecture, activation or moment arm. The results clearly 
indicate that the gains in strength with training were mainly as a result of an increase in 
specific tension [muscle force per unit physiological cross-sectional area (PCSA)] with 
increases in muscle size being a minor contributing factor. Chapter 4 explored whether this 
increase in specific tension could be related to changes occurring within the muscle itself, 
such as an alteration of muscle fibre-type composition, an increase in single fibre specific 
tension or a change in the way force is transmitted from muscle fibre to the tendon. 
Measurements of power output on an isokinetic cycle ergometer suggest that the effect of 
strength training is to increase isometric force more than power, which is consistent with 
an increase in force transmission from sarcomeres along the length of the fibre rather than 
those just at the ends, sometimes known as “lateral transmission” of force. Chapter 5 is 
concerned with the extent of variability in the response of human muscle to strength 
training, with regard to individual changes in muscle force, PCSA and specific tension. It 
is clear that most of the variation in the gains in strength occurs as a result of variation in 
specific tension and not size of the muscle. Chapters 6 and 7 explored the possibility of an 
association between specific gene variants and the inter-individual variability in muscle 
strength, size and power, and the variable changes of those phenotypes in response to 
resistance training. The results from these chapters suggest that neither the angiotensin I-
converting enzyme (ACE) I/D gene polymorphism, nor the α-actinin-3 (ACTN3) R577X 
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single nucleotide polymorphism (SNP) is responsible for the variable response to strength 
training.  
 
The inter-individual variability in untrained muscle strength 
Around half of the difference in MVC knee joint torque between untrained individuals has 
been typically associated with the anatomical CSA (ACSA) of the QF muscle (Maughan et 
al., 1983; Chapman et al., 1984; Maughan et al., 1984; Kanehisa et al., 1994; Akima et al., 
2001). However, ACSA is known to underestimate the PCSA of pennate muscles 
(Alexander & Vernon, 1975) and it is the PCSA that represents the CSA of the total 
number of muscle fibres perpendicular to their long axes, which in turn is thought to be the 
primary determinant of the force produced by a maximally activated muscle (Powell et al., 
1984). By measuring muscle architecture in each of the component QF muscles, together 
with the patellar tendon force during maximal muscle activation at the optimum knee joint 
angle, the work described in Chapter 2 demonstrated how it is possible to determine 
maximum force, PCSA and specific tension of the QF muscle when the muscle fibres in 
the whole muscle group were at their optimum length for producing peak force. However, 
the variance in QF specific tension was only slightly less than that of MVC knee joint 
torque. Thus, the results of this work show that the variability in knee joint moment in an 
homogenous group of untrained individuals was not appreciably reduced by accounting for 
inter-individual differences in voluntary muscle activation (assessed with the interpolated 
twitch technique, ITT), antagonist muscle activation (quantified by means of 
electromyography, EMG), patellar tendon moment arm length (measured using magnetic 
resonance imaging, MRI), muscle volume (calculated using MRI) and muscle fascicle 
length and pennation angle (determined via ultrasonography). The implication, therefore, is 
that differences reside in the inherent force generating capacity of the muscle fibres 
Chapter 7 General discussion 
 
 
129
themselves. As type II muscle fibres have been shown to be intrinsically stronger than type 
I fibres (Bottinelli et al., 1996; D'Antona et al., 2006; Pansarasa et al., 2009), a possibility 
is that some of the variance in QF specific tension was due to inter-individual differences 
in QF muscle fibre-type composition. However, the results reported in Chapter 4 suggest 
that in vivo muscle specific tension is not associated with myosin heavy chain (MyHC) 
isoform composition in the untrained state, thus fibre-type composition appears to be an 
unlikely cause of the differences in specific tension between people. It remains to be seen, 
however, whether differences in connective tissue content and/or costameric density 
between people leads to inter-individual differences in the degree of lateral transmission of 
force from muscle fibres to the tendon, which would affect the variability in specific 
tension (Jones et al., 1989).  
 
The effect of resistance training on in vivo muscle specific tension 
Larger increases in muscle strength than size have commonly been reported following 
short-term resistance training (Ikai & Fukunaga, 1970; Moritani & deVries, 1979; Young 
et al., 1983; Jones & Rutherford, 1987; Davies et al., 1988; Narici et al., 1989; Narici et 
al., 1996b; Ferri et al., 2003). In an attempt to explain this phenomenon, the study 
described in Chapter 3 comprehensively investigated the effect of resistance training on 
human muscle in vivo by systematically accounting for factors not routinely measured in 
the past, such as voluntary muscle activation, antagonist muscle co-activation, moment 
arm length, muscle volume and architecture before and after a period of high-intensity leg-
extension training. In doing so, the expectation was that in vivo QF muscle specific tension 
would not change following training. Greater neural adaptations than muscle hypertrophy 
have been proposed as reasons for this discrepancy (Moritani & deVries, 1979; Staron et 
al., 1991; Staron et al., 1994) but, as shown in Chapter 3, voluntary muscle activation 
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increased by a mere 3% and antagonist muscle co-activation did not change with training. 
An alternative solution to the problem might have resided in the method used to determine 
the extent of muscle hypertrophy, which has previously been defined as the change in 
muscle volume (Kanehisa et al., 2002; Charbonneau et al., 2008) or ACSA (Davies et al., 
1988; Tracy et al., 1999; Ferri et al., 2003) but neither of those indices of muscle size 
represent the CSA of the total number of muscle fibres perpendicular to their long axes. 
This is represented by the muscle PCSA, which largely determines the maximum force 
produced by a muscle (Powell et al., 1984). However, by assessing in vivo volume of the 
four component QF muscles, together with their respective fascicle lengths (Chapter 3), the 
change in QF muscle PCSA did not correspond to the increase in maximally activated 
muscle force. Thus, in Chapter 3 it is shown that in vivo QF muscle specific tension does 
increase following short-term resistance training, implying that overload training increases 
the inherent force generating capacity of the muscle.  
 
Although the underlying cause of this increase in intrinsic force remained elusive, one 
possibility was that a training-induced change in fibre-type composition might affect the 
change in muscle specific tension, as isolated single fibre specific tension has been shown 
to be fibre-type dependant in human muscle (Bottinelli et al., 1996; D'Antona et al., 2006; 
Pansarasa et al., 2009). Furthermore, a training-induced increase in the packing of 
contractile material within the muscle fibres, which would be reflected in augmented 
specific tension of isolated single fibres (Parente et al., 2008; Pansarasa et al., 2009), could 
feasibly increase the muscle specific tension calculated in vivo. Alternatively, an increase 
in the number of attachments, whether in the form of collagen (Miller et al., 2005) or 
costameric proteins, e.g. desmin and dystrophin (Woolstenhulme et al., 2006; Kosek & 
Bamman, 2008), between myofibrils and the surrounding connective tissue, could increase 
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the amount of force generated by the contractile component of muscle, thus increasing 
muscle specific tension (Jones et al., 1989). In the latter case, however, additional inter-
myofibrillar attachments would reduce the effective velocity of muscle contraction, thus 
leading to no change in power output (Jones et al., 1989). Therefore, the work described in 
Chapter 4 investigated whether a training-induced increase in muscle specific tension 
observed in vivo could be explained by changes in muscle fibre-type composition, 
determined by establishing the relative constitution of the different variants of the myosin 
heavy chain (MyHC) molecule using gel electrophoresis, increased myofibrillar protein 
density, revealed through the assessment of isolated single fibre specific tension, and/or 
lateral force transmission, estimated by assessing in vivo maximum power output before 
and after training. However, in accordance with previous studies (Staron et al., 1990; Fry 
et al., 1994; Campos et al., 2002) a decrease in the fast type IIX MyHC isoform 
composition was observed following training, which if anything would have reduced 
muscle specific tension. Furthermore, this change in MyHC IIX isoform composition was 
not associated with the increase in muscle specific tension. Additionally and in accordance 
with some previous studies (Trappe et al., 2000; Trappe et al., 2001a; Widrick et al., 2002) 
but not with others (Parente et al., 2008; Pansarasa et al., 2009), no change in single fibre 
specific tension was observed following resistance training in Chapter 4. Thus, it appears 
unlikely that increased packing of contractile material was the cause of the training-
induced increase in muscle specific tension observed in vivo in Chapters 3 and 4. However, 
the significantly larger increase in isometric force than absolute power output (Chapter 4) 
is consistent with the hypothesis that a training-induced development of additional lateral 
transmission of force from sarcomeres along the length of the fibres would increase 
specific tension at the expense of contraction velocity, thus leaving power output per unit 
muscle volume unaltered. Although it has not yet been shown in human muscle, it has been 
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demonstrated that force is not only transmitted to the tendon along the axis of the muscle 
fibre but also laterally to adjacent fibres via the matrix of connective tissue that encases 
muscle fibres (Street, 1983). Further evidence that lateral force transmission occurs comes 
from the identification of intra-sarcolemmal protein complexes, known as “costameres”, 
that are circumferentially aligned along the length of the muscle fibre (Pardo et al., 1983). 
It is thought that the main function of costameres was to mechanically link peripheral 
myofibrils to the sarcolemma, thus maintaining the integrity of the muscle cell during 
phases of contraction and relaxation (Pardo et al., 1983). Moreover, it has been shown that 
these protein structures also actually transmit muscle fibre force laterally (Danowski et al., 
1992), thus directing a certain amount of fibre force through the extra-cellular matrix to 
adjacent muscle fibres and ultimately to the tendon (Morris & Fulton, 1994; Patel & 
Lieber, 1997; Huijing, 1999; Rybakova et al., 2000).  
 
The variable response to resistance training 
It is evident that considerable variability exists in the response of human muscle to 
resistance training, concerning both the change in muscle strength and size (Hubal et al., 
2005). However, with numerous studies investigating possible associations between these 
variable training responses and genetic predisposition, it is vital to characterise the 
variability appropriately, since there are several ways in which a muscle may increase in 
strength and size. Although commonly used to characterise muscle strength (Riechman et 
al., 2004; Hubal et al., 2005; Kostek et al., 2005; Hand et al., 2007; Charbonneau et al., 
2008), neither an MVC nor the maximum load lifted in a single repetition (1 RM) 
necessarily represent the true maximum force produced by the muscle, as neither 
parameter accounts for voluntary muscle activation, antagonist muscle co-activation or 
moment arm length, all of which may change variably between people as a result of 
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training. Furthermore, the variable hypertrophic response to resistance training is often 
reported as the relative change in ACSA (Clarkson et al., 2005a; Hubal et al., 2005; 
Pescatello et al., 2006). However, this index of muscle size underestimates PCSA in 
pennate muscles (Alexander & Vernon, 1975) and may therefore provide misleading 
information regarding a change in muscle size. In addition, a muscle may increase in 
quantity, defined as the PCSA, or in its intrinsic force generating capacity, characterized as 
specific tension, which is affected by the angle of fascicle pennation. By accounting for 
training-induced changes in the ratio of optimum muscle fascicle length to muscle volume, 
as described in Chapter 5, it was possible to obtain a more accurate account of the 
variability in muscle hypertrophy by estimating changes in muscle PCSA. Taking 
maximum muscle force, PCSA and fascicle pennation angle into account, it was shown 
that the change in muscle specific tension following training was highly variable, 
demonstrating that the adaptation of human muscle to resistance training varies 
considerably regarding changes in both muscle force and hypertrophy. The cause of a 
variable change in specific tension is not known but it could be related to a variable change 
in fibre-type expression, although this appears unlikely since in Chapter 4 it was 
demonstrated that there was no association between the change in MyHC IIX and in vivo 
muscle specific tension. Another possibility is that, in some individuals, skeletal muscle 
adapts to overload through muscle hypertrophy, while others increase the number of lateral 
attachments within the muscle that would serve to increase to the force generating capacity 
but decrease the effective shortening velocity (Jones et al., 1989), thus resulting in no 
change in power output per unit muscle volume, as demonstrated in Chapter 4.  
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Methodological considerations of the current work 
It is acknowledged that the lack of a control group to assess the reliability of the post-
training results in Chapters 3, 4 and 5 is a limitation of those experimental chapters. 
Although it might have been advisable to use the contra-lateral leg as a control, there is 
considerable evidence of a cross-over effect with training of one limb, causing strength 
increases in the contra-lateral untrained limb (Komi et al., 1978; Moritani & deVries, 
1979; Zhou, 2000; Patten et al., 2001). As an alternative, a systematic assessment of the 
test-retest reliability of all the in vivo measurements used to determine in vivo QF muscle 
specific tension using the familiarisation and baseline results is reported in Chapter 2 as the 
coefficient of variation and intraclass correlation coefficient (ICC). The ICCs ranged from 
0.73 to 0.99, thus demonstrating the high reproducibility of these measurements. 
Furthermore, other investigators have reported good reproducibility for these in vivo 
measurements and have included control groups as further evidence that the changes 
observed following a period of resistance training are indeed a consequence of training and 
not measurement error (Reeves et al., 2003a; Reeves et al., 2003b, 2004b, a; Morse et al., 
2007b). Furthermore, the test-retest correlation coefficient for the assessment of in vivo 
power output and myosin heavy chain isoform composition were reported in Chapter 4 as 
3.8% and 2.9%, respectively, thus demonstrating the high reliability of these 
measurements.  
 
To accurately calculate in vivo QF muscle specific tension, it was necessary to quantify the 
level of voluntary QF muscle activation during MVC, which was achieved using the 
interpolated twitch technique (ITT), a method that has been used extensively for this 
purpose (Rutherford et al., 1986b; Jones & Rutherford, 1987; Harridge et al., 1999; 
Folland et al., 2000; Scaglioni et al., 2002; Reeves et al., 2004a, b; Williams et al., 2005). 
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The interpolated twitch technique (ITT) assesses the level of voluntary muscle activation 
essentially by assessing to what extent the motoneuron drive to the muscle is activated. 
Voluntary activation is therefore defined as the force produced during a maximal voluntary 
contraction and is given as the percentage of maximum possible force. The ITT, however, 
does not take into account the descending drive to the motoneurons and does not 
distinguish between motor unit recruitment and firing rates that would affect the potential 
maximal force output of a muscle. Reports of a non-linear inverse relationship between 
superimposed and voluntary force have questioned the validity of the ITT in determining 
voluntary activation (Bulow et al., 1993; Dowling et al., 1994; Lyons et al., 1996). 
However, by carefully controlling the factors thought to contribute to non-linearity in this 
relationship the validity and reliability of this technique is improved. Firstly, the 
stimulating electrodes were carefully placed over the QF muscle, so as to minimise the 
stimulation of synergist and antagonist muscles during the ITT protocol. Secondly, the QF 
muscle was stimulated at a joint angle of 90° knee flexion, thus reducing the effect of slack 
in the series elastic component on the calculated activation level when assessed at smaller 
joint angles (Becker & Awiszus, 2001; Kubo et al., 2004; Bampouras et al., 2006). 
Furthermore, due care was taken to minimise compliance in the isokinetic dynamometer 
system by adding a counter-weight to the lever arm. Thirdly, it has been suggested that a 
single superimposed twitch is unable to detect sub-optimal motor-unit firing rates 
(Maffiuletti et al., 2002). However, it has been shown that the effect of stimuli number is 
negligible as there is no difference in the calculated level of activation when one, two, 
four, five or eight stimuli are administered (Behm et al., 1996; Bampouras et al., 2006). 
Although the aforementioned precautions taken during the current project do not remove 
all limitations of the ITT, it is one of the best available techniques to obtain an insight into 
voluntary activation, and hence inclusion of the ITT is better than not using it at all. 
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While it is acknowledged that the estimation of hamstring co-activation during an 
isometric knee extension MVC using surface EMG measurements is subject to a variety of 
technical issues, care was taken to maximise test-retest reliability of this assessment. Re-
location of EMG electrodes in subsequent tests was done as accurately as possible by 
marking the original electrode location in relation to anatomical landmarks on a sheet of 
acetate, and skin surface impedance was reduced to below 5 kΩ. However, it is not known 
how training would have affected levels of subcutaneous and intramuscular fat, which 
would have also influenced the EMG signal.  
 
It has been demonstrated using cadaver knees that the tension developed in the QF tendon 
is ~1.5 times higher than in the patellar tendon over the range of joint angles used in the 
present study, i.e. that the patello-femoral joint does not function as a frictionless pulley 
(Buff et al., 1988). If this were the case in vivo, untrained QF muscle specific tension 
values using Method 1 described in Chapter 2 would have been ~45 N⋅cm-2, considerably 
higher than previous values determined with animal muscle (Close, 1972; Degens et al., 
1995). Although this discrepancy in forces at the QF and patellar tendons should be 
acknowledged, applying ratios gained from cadaveric data may well give a false indication 
of the tendon force relationship in vivo. Moreover, this issue does not affect the 
comparison of Methods 1 and 2 in Chapter 2 and, as there was no change in joint angle 
with training (Chapter 3), its influence on post-training changes in tendon force would be 
negligible (assuming that any frictional resistance around the knee is unchanged by 
training).  
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One of the novel approaches of this thesis is that the geometry (fascicle length and 
pennation angle) of each of the four component QF muscles was assessed using two-
dimensional (2D) ultrasonography during MVC at optimum knee joint angle. As rotation 
of the ultrasound probe relative to the plane of contraction is known to affect the measured 
fascicle length (Klimstra et al., 2007), care was taken to eliminate probe movement during 
each measurement trial. Following each assessment, the ultrasound scan was checked for 
probe movement and if this was observed, the trial was repeated. Although it is 
acknowledged that 2D images would not account for possible fascicle rotation, the 
ultrasound images were of good quality and fascicles were easily identifiable and able to 
be tracked along their lengths within the field of view. Muscle PCSA was calculated by 
dividing muscle volume by fascicle length (Haxton, 1944; Alexander & Vernon, 1975; 
Maganaris et al., 2001; Reeves et al., 2004a), with the latter measured in the mid-sagittal 
plane of the central portion of each muscle. Therefore, it was assumed the muscle was 
cylindrical in shape and that its fascicles were a constant length, which is supported by 
previous in vivo (Narici et al., 1996a; Maganaris et al., 1998; Maganaris & Baltzopoulos, 
1999) and cadaveric (Friederich & Brand, 1990) findings in human muscles. In the resting 
state, however, it has been shown that in vivo QF muscle architecture varied along the 
muscle length (Blazevich et al., 2006). Although measuring muscle geometry at multiple 
sites in each constituent muscle is feasible in resting conditions, obtaining such extensive 
measurements during an MVC is problematic; it would require at least 12 MVCs 
(assuming 3 sites per muscle), which is likely to induce errors due to the development of 
muscular fatigue (in addition to the MVCs performed at each of the remaining two joint 
angles).  
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When using MRI to measure QF muscle volume in young women, it has been reported that 
a small proportion (~6%) constitutes non-contractile material (Macaluso et al., 2002). 
Therefore, it is recognised that by not accounting for this component in the current thesis, 
it is possible that the volume of contractile material was slightly overestimated, thus 
leading to an overestimation of PCSA and an underestimation of specific tension. 
However, as the non-contractile component of the ankle dorsiflexor muscle group is 25% 
higher in young women than in men of the same age (Holmback et al., 2002), it is likely 
that the level of intramuscular fat in the male participants of the present study was 
negligible and the influence on the calculation of muscle PCSA, if any, would have been 
minimal.  
 
Implications for future research 
The work described in this thesis explored the possible reasons for a large variation in 
inter-individual strength (Maughan et al., 1983; Chapman et al., 1984; Maughan et al., 
1984; Kanehisa et al., 1994; Akima et al., 2001) and found that differences in voluntary 
activation, antagonist co-activation, moment arm length, muscle volume and muscle 
architecture could not fully explain this variance. Therefore, future studies should focus on 
investigating possible factors causing inter-individual differences in the intrinsic force of 
the muscle. Although the present thesis has demonstrated that inter-individual differences 
in muscle fibre-type composition are unlikely to explain this variability, quantification of 
intramuscular lateral attachments in the form of connective tissue or costameres might 
offer an explanation for this variance in muscle specific tension, based on differences in 
the extent of lateral force transmission.  
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The observed increase in muscle specific tension following resistance training described in 
Chapter 3 suggests that previous reports of disproportionate increases in muscle strength 
and size following resistance training (Ikai & Fukunaga, 1970; Moritani & deVries, 1979; 
Young et al., 1983; Jones & Rutherford, 1987; Davies et al., 1988; Narici et al., 1989; 
Narici et al., 1996b; Ferri et al., 2003) are not explained by changes in voluntary 
activation, antagonist co-activation, moment arm length, muscle volume, or architecture. 
As described in Chapter 4, no association was found between the increases in muscle 
specific tension and change in MyHC isoform composition, neither was there a change in 
power output per unit muscle volume. Consequently, a change in lateral force transmission 
remains a strong possibility for explaining these observations. Training-induced changes in 
muscle collagen or costameric protein content could provide a possible mechanism for this 
increase in muscle specific tension. Furthermore, it is feasible that resistance training 
causes an increase in myofilament packing, thus increasing the specific tension of the 
individual muscle fibres. This possibility could be examined by determining the contractile 
properties of isolated human muscle fibres before and after a period of resistance training. 
However, Chapter 4 of the current thesis and recent reports have provided equivocal 
results (Trappe et al., 2000; Widrick et al., 2002; Parente et al., 2008; Pansarasa et al., 
2009), thus demonstrating the need for clarification on this issue. Comparing the force 
generated by an isolated bundle of fibres, where lateral transmission would be expected to 
play a role, with the force from single fibres where lateral transmission is not a factor, 
might throw some light on this question.  
 
The results described in Chapter 5 illustrate the extent of variation in the response to 
resistance training (at least in the short term), regarding a change in maximum force, 
muscle PCSA and specific tension. As a result, a greater understanding of the way in 
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which human muscle adapts to strength training was achieved. Future investigations into 
possible mechanisms underlying these variable responses should consider the variable 
changes in force, PCSA and specific tension ascertained in Chapter 5 of this thesis. The 
discovery of genetic polymorphisms that identify high and low responders to strength 
training would considerably improve our understanding of the factors that regulate muscle 
size and strength. However, in the search for associations between gene variants and the 
muscle response to resistance training, it is important to distinguish between gains in 
strength and increases in muscle size, since it would appear that these are two separate 
responses to training. No significant associations were observed concerning the ACE I/D 
polymorphism or the ACTN3 R577X SNP and the variability in muscle specific tension or 
the variable response to resistance training, although the ACTN3 genotype does appear to 
be related to muscle volume and power output. It is suggested that future studies should 
investigate variants of genes encoding cytoskeletal proteins that are involved in the lateral 
transmission of muscle force. Such studies might provide further evidence for lateral force 
transmission underlying the differences in specific tension and the variable response to 
resistance training.  
 
Conclusions 
Specific tension of the human QF muscle has been calculated in vivo from the most 
comprehensive set of measurements to date and the results indicate that most of the inter-
individual variance in MVC torque arises from factors other then differences in the 
activation, size and geometry of the muscle. By systematically accounting for these factors, 
in vivo QF muscle specific tension was shown to increase following resistance training. 
This increase was not found to be associated with a change in fibre-type composition or an 
increase in isolated single fibre specific tension but, as power output per muscle volume 
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remained unaltered after training, a change in lateral force transmission is a conceivable 
mechanism for a training-induced increase in muscle specific tension. Furthermore, it has 
been clearly demonstrated that the response of human muscle to high-intensity resistance 
training varies considerably between previously untrained young men. Large differences in 
the hypertrophic response of the muscle were not related to the variable response of muscle 
force, giving rise to variable increases in muscle specific tension. Certain candidate gene 
variants have provided evidence of genetic predisposition influencing muscle strength, size 
and power but not the human muscle response to resistance training. However, it is 
acknowledged that the genetic determinants of muscle phenotype and the response to 
overload are likely to be polygenic and more studies are required to elucidate new 
candidate gene variants. Moreover, in searching for mechanisms, whether of a genetic or 
other nature, underlying these differences or changes in muscle function, it is important 
that the complexity of the muscle response is clearly appreciated.  
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